Handbook of Atypical Parkinsonism


Handbook of Atypical Parkinsonism

Improved diagnostic sophistication is increasingly enabling neurologists to differentiate between Parkinson's disease and other atypical parkinsonism (AP), such as multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, and dementia with Lewy bodies. The Handbook of Atypical Parkinsonism is a comprehensive survey of all diseases of this category, providing an authoritative guide to the recognition, diagnosis and management of these disorders. Each chapter follows a common structure, commencing with the full basic science of the disorder under consideration, followed by descriptions of the clinical picture and differential diagnosis. Subsequent chapters discuss current and future therapeutic approaches to these difficult conditions. Written and edited by leading practitioners in the field, clinicians in neurology and other specialties will find this book essential to the understanding and diagnosis of this complex group of disorders.


 Reviews:

"…Covers most atypical Parkinsonism disorders quite well…excellent book for practitioners who care for patients with these conditions…A worthwhile source of information and should be on hospital library bookshelves." Doody's Review Services

Aarsland D , Anderson K , Larsen JP , et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003; 60(3): 387–92.
Aarsland D , Anderson K , Larsen JP , et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003; 60: 387–392.
Aarsland D , Ballard C , Larsen J , et al. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int J Geriatr Psychiatry 2001; 16: 528–36.
Aarsland D , Ballard C , Walker Z , et al. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial. Lancet Neurol 2009; 8(7): 613–18.
Aarsland D , Kurz M , Beyer M , et al. Early discriminatory diagnosis of dementia with Lewy bodies. Dement Geriatr Cogn Disord 2008; 25: 195–205.
Aarsland D , Litvan I , Larsen JP. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001; 13: 42–9.
Aarsland D , Perry R , Brown A , et al. Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Ann Neurol 2005; 58: 773–6.
Abbott RD , Ross GW , White LR , et al. Excessive daytime sleepiness and the future risk of Parkinson's disease. Mov Disord 2005; 20: S101.
Abdo WF , Bloem BR , Van Geel WJ , et al. CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease. Neurobiol Aging 2007; 28: 742–7.
Abdo WF , Borm GF , Munneke M , et al. Ten steps to identify atypical parkinsonism. J Neurol Neurosurg Psychiatry 2006; 77(12): 1367–9.
Abdo WF , van de Warrenburg BP , Munneke M , et al. CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia. Neurology 2006; 67: 474–9.
Abe S , Tojo K , Ichida K , et al. A rare case of idiopathic hypoparathyroidism with varied neurological manifestations. Intern Med 1996; 35(2): 129–34.
Abele M , Riet A , Hummel T , et al. Olfactory dysfunction in cerebellar ataxia and multiple system atrophy. J Neurol 2003; 250: 1453–5.
Abrey LE , Waters CH . Basal ganglia calcification after mumps encephalitis. Mov Disord 1996; 11(6): 755–6.
Adams MR , Van Bogaert L , van der Eecken H . Nigro-striate and cerebello-nigro-striate degeneration. Clinical uniqueness and pathological variability of presenile degeneration of the extrapyramidal rigidity type. Psychiatr Neurol (Basel) 1961; 142: 219–59.
Adler CH , Stern MB , Brooks ML . Parkinsonism secondary to bilateral striatal fungal abscesses. Mov Disord 1989; 4(4): 333–7.
Aggarwal A , Vaidya S , Shah S , et al. Reversible Parkinsonism and T1W pallidal hyperintensities in acute liver failure. Mov Disord 2006; 21(11): 1986–90.
Aharon-Peretz J , Rosenbaum H, Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl J Med 2004, 351: 1972–7.
Akiguchi I , Ishii M , Watanabe Y , et al. Shunt-responsive parkinsonism and reversible white matter lesions in patients with idiopathic NPH. J Neurol 2008; 255(9): 1392–9.
Akyol A , Akyildiz UO , Tataroglu C. Vascular Parkinsonism: a case of lacunar infarction localized to mesencephalic substantia nigra. Parkinsonism Relat Disord 2006; 12(7): 459–61.
Al-Chalabi A , Dürr A , Wood NW , et al. NNIPPS Genetic Study Group. Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy. PLoS One 2009; 4(9): e7114.
Alam M , Smith G , Bleasdale-Barr K , et al. Effects of the peptide release inhibitor, octreotide, on daytime hypotension and on nocturnal hypertension in primary autonomic failure. J Hypertens 1995; 13: 1664–9.
Albin RL , Minoshima S , Damato CJ , et al. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology 1996; 47: 462–6.
Aldrich MS , Foster NL , White RF , et al. Sleep abnormalities in progressive supranuclear palsy. Ann Neurol 1989; 25: 577–81.
Alfonsi E , Versino M , Merlo IM , et al. Electrophysiologic patterns of oral-pharyngeal swallowing in parkinsonian syndromes. Neurology 2007; 68(8): 583–9.
Alkelai A , Greenbaus L , Rigbi A , et al. Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients. Psychopharmacology (Berl) 2009; 206(3): 491–9.
Alp R , Alp SI , Ure H. Cavernous hemangioma: a rare cause for secondary parkinsonism: a case report. Int J Neurosci 2009; 119(11): 2112–17.
Anschel DJ , Simon DK , Llinas R , et al. Spongiform encephalopathy mimicking corticobasal degeneration. Mov Disord 2002; 17: 606–7.
Apartis E , Gaymard B , Verhaeghe S , et al. Predominant cortical dysfunction in Guadeloupean parkinsonism. Brain 2008; 131(10): 2701–9.
Apaydin H , Ahlskog JE , Parisi JE , et al. Parkinson disease neuropathology: later developing dementia and loss of the levodopa response. Arch Neurol 2002; 59: 102–12.
Arai H , Morikawa Y , Higuchi M , et al. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology. Biochem Biophys Res Commun 1997; 236: 262–4.
Arima K , Murayama S , Mukoyama M , et al. Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 1. Neuronal cytoplasmic inclusions. Acta Neuropathol 1992; 83: 453–60.
Armstrong RA , Cairns NJ , Lantos PL. Multiple system atrophy (MSA): topographic distribution of the alpha-synuclein-associated pathological changes. Parkinsonism Relat Disord 2006; 12: 356–62.
Armstrong RA , Lantos PL, Cairns NJ. Spatial patterns of alpha-synuclein positive glial cytoplasmic inclusions in multiple system atrophy. Mov Disord 2004; 19: 109–12.
Arvanitakis Z , Wilson RS , Bienias JL , et al. Diabetes and parkinsonian signs in older persons. Alzheimer Dis Assoc Disord 2007; 21(2): 144–9.
Asada T , Takayama Y , Tokuriki Y , et al. Gliomatosis cerebri presenting as a parkinsonian syndrome. J Neuroimaging 2007; 17(3): 269–71.
Avanzino L , Marinelli L , Buccolieri A , et al. Creutzfeldt-Jakob disease presenting as corticobasal degeneration: a neurophysiological study. Neurol Sci 2006; 27: 118–21.
Averbuch-Heller L , Paulson GW , Daroff RB , et al. Whipple's disease mimicking progressive supranuclear palsy: the diagnostic value of eye movement recording. J Neurol Neurosurg Psychiatry 1999; 66(4): 532–5.
Averbuch-Heller L , Paulson GW , Daroff RB , et al. Whipple's disease mimicking progressive supranuclear palsy: the diagnostic value of eye movement recording. J Neurol Neurosurg Psychiatry 1999; 66(4): 532–5.
Averbuch-Heller L , Paulson GW , Daroff RB , et al. Whipple's disease mimicking progressive supranuclear palsy: the diagnostic value of eye movement recording. J Neurol Neurosurg Psychiatry 1999; 66: 532–5.
Aziz NA , van der Marck MA , Pijl H , et al. Weight loss in neurodegenerative disorders. J Neurol 2008; 255(12): 1872–80.
Baba Y , Uitti RJ , Farrer MJ , et al. Sporadic SCA8 mutation resembling corticobasal degeneration. Parkinsonism Relat Disord 2005; 11: 147–50.
Ball JA , Lantos PL , Jackson M , et al. Alien hand sign in association with Alzheimer's histopathology. J Neurol Neurosurg Psychiatry 1993; 56: 1020–3.
Ballard C , Holmes C , McKeith I , et al. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer disease. Am J Psychiatry 1999; 156: 1039–45.
Ballard CG , McKeith IG , Swann A , et al. One year follow-up of parkinsonism in dementia with Lewy bodies. Dement Geriatr Cogn Disord 2000; 11: 219–22.
Ballard CG , O'Brien J , Morris CM , et al. The progression of cognitive impairment in dementia with Lewy bodies. Int J Geriatr Psychiatry 2001; 16: 499–503.
Ballard CG , O'Brien JT , Swann AG , et al. The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: persistence and new cases over 1 year of follow-up. J Clin Psychiatry 2001; 62: 46–9.
Ballard CG , Shaw F , Lowery K , et al. The prevalence, assessment and associations of falls in dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord 1999; 10: 97–103.
Ballard CG , Ziabreva I , Perry R , et al. Differences in neuropathologic characteristic across the Lewy body dementia spectrum. Neurology 2006; 67: 1931–4.
Baloh RH , Salavaggione E , Milbrandt J , et al. Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle. Arch Neurol 2007; 64(7): 998–1000.
Barber PA , Varma AR . Lloyd JJ , et al. The electroencephalogram in dementia with Lewy bodies. Acta Neurol Scand 2000; 101: 53–6.
Barber R , Panikkar A , McKeith IG . Dementia with Lewy Bodies: diagnosis and management. Int J Geriatr Psychiatry 2001; 16(suppl 1): S12–18.
Bardien S , Abrahams F , Soodyall H , et al. A South African mixed ancestry family with Huntington disease-like 2: clinical and genetic features. Mov Disord 2007; 22(14): 2083–9.
Barichella M , Marczewska A , De NR , et al. Special low-protein foods ameliorate postprandial off in patients with advanced Parkinson's disease. Mov Disord 2006; 21(10): 1682–7.
Bazarian JJ , Cernak I , Noble-Haeusslein L , et al. Long-term neurologic outcomes after traumatic brain injury. J Head Trauma Rehabil 2009; 24(6): 439–51.
Beck RO , Betts CD , Fowler CJ. Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases. J Urol 1994; 151: 1336–41.
Behrman AL , Teitelbaum P , Cauraugh JH. Verbal instructional sets to normalise the temporal and spatial gait variables in Parkinson's disease. J Neurol Neurosurg Psychiatry 1998; 65(4): 580–2.
Beleza P , Soares-Fernandes J , Jordão MJ , et al. From juvenile parkinsonism to encephalitis lethargica, a new phenotype of post-streptococcal disorders: case report. Eur J Paediatr Neurol 2008; 12(6): 505–7.
Belfor N , Amici S , Boxer AL , et al. Clinical and neuropsychological features of corticobasal degeneration. Mech Ageing and Dev 2006; 127: 203–7.
Belfor N , Amici S , Boxer AL , et al. Clinical and neuropsychological features of corticobasal degeneration. Mech Ageing Dev 2006; 127: 203–7.
Ben Shlomo Y , Wenning GK , Tison F , et al. Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology 1997; 48: 384–93.
Benaderette S , Zanotti Fregonara P , Apartis E , et al. Psychogenic parkinsonism: a combination of clinical, electrophysiological, and [(123)I]-FP-CIT SPECT scan explorations improves diagnostic accuracy. Mov Disord 2006; 21(3): 310–17.
Benarroch EE , Schmeichel AM , Low PA , et al. Involvement of medullary serotonergic groups in multiple system atrophy. Ann Neurol 2004; 55: 418–22.
Benarroch EE , Schmeichel AM , Sandroni P , et al. Involvement of hypocretin neurons in multiple system atrophy. Acta Neuropathol 2007; 113: 75–80.
Benarroch EE , Schmeichel AM , Sandroni P . et al. Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease. Neurology 2006; 66: 378–83.
Benarroch EE. Brainstem in multiple system atrophy: clinicopathological correlations. Cell Mol Neurobiol 2003; 23: 519–26.
Benincasa D , Romano A , Mastronardi L , et al. Hemiparkinsonism due to frontal meningioma. Acta Neurol Belg 2008; 108(1): 29–32.
Bennett P , Bonifati V , Bonuccelli U , et al. Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism Consortium. Neurology 1998: 51: 982–5.
Bensimon G , Ludolph A , Agid Y , et al. NNIPPS Study Group. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain 2009; 132: 156–71.
Bensimon G , Ludolph A , Agid Y , et al. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain 2009; 132(Pt 1): 156–71.
Benussi L , Binetti G , Sina E , et al. A novel deletion in progranulin gene is associated with FTDP-17 and CBS. Neurobiol Aging 2008; 29: 427–35.
Berciano J , Monton FI , Maeso MC , et al. [Man aged 49 years suffering from progressive clinical picture with palatal tremor, segmental myoclonus, ataxia, parkinsonism, amyotrophy, pyramidal signs, supranuclear ophthalmoplegia and cognitive decline]. Neurologia 2002; 17: 237–43.
Berg D , Hochstrasser H . Iron metabolism in Parkinsonian syndromes. Mov Disord 2006; 21(9): 1299–310.
Bergeron C , Pollanen MS , Weyer L , et al. Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol 1996; 40: 893–900.
Bergevin PR , Patwardhan VC , Weissman J , et al. Letter: Neurotoxicity of 5-fluorouracil. Lancet 1975; 1(7903): 410.
Bergman J , Lerner V . Successful use of donepezil for the treatment of psychotic symptoms in patients with Parkinson's disease. Clin Neuropharmacol 2002; 25(2): 107–10.
Bhanji NH , Margolese HC .Extrapyramidal symptoms related to adjunctive nizatidine therapy in an adolescent receiving quetiapine and paroxetine. Pharmacotherapy 2004; 24(7): 923–5.
Bharadwaj R , Grover S . Parkinsonism and akathisia with quetiapine: three case reports. J Clin Psychiatry 2008; 69(7): 1189–91.
Bhatia KP , Lang AE. Corticobasal degeneration. In: Flint Beal M , Lang AE , Ludolph A , eds. Neurodegenerative diseases. Cambridge: Cambridge University Press, 2005; 682–96.
Bhatia KP , Lee MS , Rinne JO , et al. Corticobasal degeneration look-alikes. Adv Neurol 2000; 82: 169–82.
Bjarkam CR , Nielsen MS , Glud AN , et al. Neuromodulation in a minipig MPTP model of Parkinson disease. Br J Neurosurg 2008; 22(Suppl 1): S9–12.
Blin J , Baron JC , Dubois B , et al. Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol 1990; 47: 747–52.
Bloem BR , Bhatia KP. Gait and balance in basal ganglia disorders. In: Bronstein AM , Brandt T , Nutt JG , Woollacott MH , eds. Clinical Disorders of Balance, Posture and Gait. London: Arnold, 2004; 173–206.
Boesch SM , Wenning GK , Ransmayr G , et al. Dystonia in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002; 72: 300–3.
Boeve BF , Josephs KA , Drubach DA . Current and future management of the corticobasal syndrome and corticobasal degeneration. Handb Clin Neurol 2008; 89: 533–48.
Boeve BF , Lang AE , Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 2003; 54 (Suppl 5): S15–19.
Boeve BF , Maraganore DM , Parisi JE , et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999; 53: 795–800.
Boeve BF , Maraganore DM , Parisi JE , et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999; 53: 795–800.
Boeve BF , Silber M , Ferman T . REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies. J. Geriatr Psychiatry Neurol 2004; 17: 146–57.
Boeve BF , Silber M , Ferman T. Current management of sleep disturbances in dementia. Curr Neurol Neurosci Rep 2001; 2(2): 169–77.
Boeve BF , Silber M , Ferman T. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med 2003; 4: 281–4.
Boeve BF , Silber MH , Ferman TJ , et al. Association of REM sleep behaviour disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 2001; 16: 622–30.
Boeve BF. Clinical, diagnostic, genetic and management issues in dementia with Lewy bodies. Clin Sci 2005; 109: 343–54.
Bogaerts V , Engelborghs S , Kumar-Singh S , et al. A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder. Brain 2007; 130: 2277–91.
Bologna M , Agostino R , Gregori B , et al. Voluntary, spontaneous and reflex blinking in patients with clinically probable progressive supranuclear palsy. Brain 2009; 132: 502–10.
Bonanni L , Thomas A , Tiraboschi P , et al. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up. Brain 2008; 131(3): 690–705.
Bonelli SB , Ransmayr G , Steffelbauer M , et al. L-dopa responsiveness in dementia with Lewy bodies, Parkinson's disease with and without dementia. Neurology 2004; 63(2): 376–8.
Borroni B , Gardoni F , Parnetti L , et al. Pattern of tau forms in CSF is altered in progressive supranuclear palsy. Neurobiol Aging 2009; 30: 34–40.
Borroni B , Malinverno M , Gardoni F , et al. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Neurology 2008; 71: 1796–803.
Bosch J , Vilalta J , Tintore M , et al. [Parkinsonian hemi-syndrome as the initial manifestation of supratentorial cystic hemangioblastoma in a patient with Von Hippel-Lindau disease]. Rev Neurol 1998; 26(150): 221–3.
Bostantjopoulou S , Katsarou Z , Kazis A , et al. Neuroacanthocytosis presenting as parkinsonism. Mov Disord 2000; 15(6): 1271–3.
Bostantjopoulou S , Katsarou Z , Michael M , et al. Reversible parkinsonism due to chronic bilateral subdural hematomas. J Clin Neurosci 2009; 16(3): 458–60.
Bostantjopoulou S , Katsarou Z , Petridis A . Relapsing hemiparkinsonism due to recurrent meningioma. Parkinsonism Relat Disord 2007; 13(6): 372–4.
Bouffard JP , Mena H , Ripple M , et al. Mesencephalic cryptococcal abscesses presenting with parkinsonism as an initial manifestation of AIDS. Mov Disord 2003; 18(11): 1354–7.
Bower JH , Dickson DW , Taylor L , et al. Clinical correlates of the pathology underlying parkinsonism: a population perspective. Mov Disord 2002; 17: 910–16.
Bower JH , Maraganore DM , McDonnell SK , et al. Incidence and distribution of parkinsonism in Olmsted County; Minnesota, 1976–1990. Neurology 1999; 52: 1214–20.
Bower JH , Maraganore DM , McDonnell SK , et al. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 1997; 49(5): 1284–8.
Bower JH , Maraganore DM , McDonnell SK , et al. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 1997; 49: 1284–8.
Boxer AL , Geschwind MD , Belfor N , et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol 2006; 63: 81–6.
Brücke T , Asenbaum S , Pirker W , et al. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. J Neural Transm Suppl 1997; 50: 9–24.
Braak H , Del Tredici K , Rub U , et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197–211.
Braak H , Sastre M , Bohl JR , et al. Parkinson's disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 2007; 113: 421–9.
Brashear A , Dobyns WB , de Carvalho Aguiar P, et al. The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene. Brain 2007; 130(3): 828–35.
Braune S , Reinhardt M , Schnitzer R , et al. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology 1999; 53: 1020–5.
Braune S. The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clin Auton Res 2001; 11: 351–5.
Brenneis C , Egger K , Scherfler C , et al. Progression of brain atrophy in multiple system atrophy. A longitudinal VBM study. J Neurol 2007; 254(2): 191–6.
Brenneis C , Seppi K , Schocke M , et al. Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2004; 75: 246–9.
Brettschneider J , Petzold A , Süssmuth SD , et al. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes. Mov Disord 2006; 21: 2224–7.
Brettschneider J , Petzold A , Sussmuth SD , et al. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes. Mov Disord 2006; 21: 2224–7.
Brewer GJ , Askari F , Lorincz MT , et al. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Arch Neurol 2006; 63(4): 521–7.
Briani C , Cagnin A , Chierichetti F , et al. Thiethylperazine-induced parkinsonism: in vivo demonstration of dopamine D2 receptors blockade. Eur J Neurol 2004; 11(10): 709–10.
Briel RC , McKeith IG , Barker WA , et al. EEG findings in dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1999; 66: 401–3.
Bronner G , Royter V , Korczyn AD , et al. Sexual dysfunction in Parkinson's disease. J Sex Marital Ther 2004; 30(2): 95–105.
Brooks DJ , Ibanez V , Sawle GV , et al. Differing patterns of striatal 18-F-Dopa uptake in Parkinson`s disease, multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1990; 28: 547–55.
Brooks DJ , Ibanez V , Sawle GV , et al. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann Neurol 1992; 31: 184–92.
Brooks DJ , Seppi K. Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov Disord 2009; 24(7): 949–64.
Broussolle E, Thobois S. [Genetics and environmental factors of Parkinson disease]. Rev Neurol (Paris) 2002; 158(Spec 1): S11–23.
Brown J , Lantos PL , Roques P , et al. Familial dementia with swollen achromatic neurons and corticobasal inclusion bodies: a clinical and pathological study. J Neurol Sci 1996; 135: 21–30.
Brown RC , Lockwood AH , Sonawane BR . Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect 2005; 113: 1250–6.
Brown RG , Jahanshahi M , Quinn N , et al. Sexual function in patients with Parkinson's disease and their partners. J Neurol Neurosurg Psychiatry 1990; 12: 480–6.
Brunt ER , van Weerden TW , Pruim J , et al. Unique myoclonic pattern in corticobasal degeneration. Mov Disord 1995; 10: 132–42.
Brusa A , Stoehr R , Pramstaller PP. Progressive supranuclear palsy: new disease or variant of postencephalitic parkinsonism? Mov Disord 2004; 19: 247–52.
Buechner S , De Cristofaro MT , Ramat S , et al. Parkinsonism and Anderson Fabry's disease: a case report. Mov Disord 2006; 21(1): 103–7.
Bugiani O , Murrell JR , Giaccone G , et al. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol 1999; 58: 667–77.
Bullock R , Cameron A. Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series. Curr Med Res Opin 2002; 18(5): 258–64.
Burke RE, Dauer WT, Vonsattel JP. A critical evaluation of the Braak staging scheme for Parkinson's disease. Ann Neurol 2008; 64(5): 485–91.
Burkhard PR , Delavelle J , Du Pasquier R , et al. Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration. Arch Neurol 2003; 60(4): 521–8.
Burkhardt K , Heuberger F , Delavelle J . Pilocytic astrocytoma in the elderly. Clin Neuropathol 2007; 26(6): 306–10.
Burn DJ , Lees AJ. Progressive supranuclear palsy: where are we now? Lancet Neurol 2001; 1: 359–69.
Burn DJ , Rowan EN , Minett T , et al. Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study. Mov Disord 2003; 18: 884–9.
Burn DJ , Sawle GV , Brooks DJ. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data. J Neurol Neurosurg Psychiatry 1994; 57: 278–84.
Burn DJ. Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease. Mov Disord 2002; 17: 445–54.
Burton EJ , Barber R , Mukaetova-Ladinska EB , et al. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis. Brain 2009; 132(1): 195–203.
Cagnon JF , Bedard MA , Fantini ML , et al. REM sleep behaviour disorder and REM sleep without atonia in Parkinson's disease. Neurology 2002; 59: 585–9.
Campdelacreu J , Kumru H , Tolosa E , et al. Progressive supranuclear palsy syndrome induced by clebopride. Mov Disord 2004; 19: 482–4.
Caparros-Lefebvre D , Elbaz A. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group. Lancet 1999; 354(9175): 281–6.
Caparros-Lefebvre D , Lees AJ . Atypical unclassifiable parkinsonism on Guadeloupe: an environmental toxic hypothesis. Mov Disord 2005; 20(Suppl 12): S114–18.
Cardoso F. HIV-related movement disorders: epidemiology, pathogenesis and management. CNS Drugs 2002; 16(10): 663–8.
Casarejos MJ , Menendez J , Solano RM , et al, Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline. J Neurochem 2006; 97: 934–46.
Case records of the Massachusetts General Hospital . Weekly clinicopathological exercises. Case 38–1985: a 66-year-old man with progressive neurologic deterioration. N Engl J Med 1985; 313: 739–48.
Case Records of the Massachusetts General Hospital . Weekly clinicopathological exercises. Case 46–1993: a 75-year-old man with right-sided rigidity, dysarthria, and abnormal gait. N Engl J Med 1993; 329:1560–7.
Chacko RC , Hurley RA , Harper RG , et al. Clozapine for acute and maintenance treatment of psychosis in Parkinson's disease. Fall 1995; 7(4): 471–5.
Chade AR , Kasten M , Tanner CM . Nongenetic causes of Parkinson's disease. J Neural Transm Suppl 2006; 70: 147–51.
Chartier-Harlin MC , Kachergus J , Roumier C , et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004; 364: 1167–9.
Chaudhuri KR , Healy DG , Schapira A. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006; 5: 235–45.
Chaudhuri KR , Naidu Y. Early Parkinson's disease and non-motor issues. J Neurol 2008; 255(Suppl 5): 33–8.
Chaudhuri KR. Nocturnal symptoms complex in PD and its management. Neurology 2003; 61: S17–23.
Chen R , Ashby P , Lang AE. Stimulus-sensitive myoclonus in akinetic-rigid syndromes. Brain 1992; 115: 1875–88.
Chio A , Magnani C , Schiffer D. Prevalence of Parkinson's disease in northwestern Italy: comparison of tracer methodology and clinical ascertainment of cases. Mov Disord 1998; 13: 400–5.
Cho JW , Kim SY , Park SS , et al. Spinocerebellar ataxia type 12 was not found in Korean Parkinsonian patients. Can J Neurol Sci 2008; 35(4): 488–90.
Choi IS. Parkinsonism after carbon monoxide poisoning. Eur Neurol 2002; 48(1): 30–3.
Chou KL , Evatt M , Hinson V , et al. Sialorrhea in Parkinson's disease: a review. Mov Disord 2007; 22(16): 2306–13.
Chou KL , Friedman JH. Drug-induced parkinsonism in the elderly. Future Neurol 2007; 2: 307–16.
Christine CW , Langston JW , Turner RS , et al. The neurophysiology and effect of deep brain stimulation in a patient with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism. J Neurosurg 2009; 110(2): 234–8.
Christodoulou C , Papadopoulou A , Rizos E , et al. Extrapyramidal side effects and suicidal ideation under fluoxetine treatment: a case report. Ann Gen Psychiatry 2010; 9: 5.
Chrysostome V , Tison F , Yekhlef F , et al. Epidemiology of multiple system atrophy: a prevalence and pilot risk factor study in Aquitaine, France. Neuroepidemiology 2004; 23: 201–8.
Chutorian AM , Bojko A , Heier L , et al. Toxic pediatric parkinsonism: report of a child with metabolic studies and response to treatment. J Child Neurol 2003; 18(11): 812–15.
Ciucci MR , Barkmeier-Kraemer JM , Sherman SJ. Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson's disease. Mov Disord 2008; 23(5): 676–83.
Clark LN , Ross BM , Wang Y , et al. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology 2007; 69: 1270–7.
Clay PG , Adams MM . Pseudo-Parkinson disease secondary to ritonavir-buspirone interaction. Ann Pharmacother 2003; 37(2): 202–5.
Clayton PT , Smith I , Harding B , et al. Subacute combined degeneration of the cord, dementia and parkinsonism due to an inborn error of folate metabolism. J Neurol Neurosurg Psychiatry 1986; 49(8): 920–7.
Collins SJ , Ahlskog JE , Parisi JE , et al. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry 1995; 58: 167–73.
Collins SJ , Ahlskog JE , Parisi JE , et al. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry 1995; 58: 167–73.
Colloby SJ , Fenwick JD , Williams ED , et al. A comparison of 99Tc-HMPAO SPECT changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med 2002; 29: 615–22.
Colosimo C , Albanese A , Hughes AJ , et al. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol 1995; 52: 294–8.
Colosimo C , Albanese A , Hughes AJ , et al. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol 1995; 52: 294–8.
Colosimo C , Geser F , Benarroch EE , et al. Multiple system atrophy. In: Gilman S , ed. Neurobiology of disease. San Diego (CA): Academic Press, 2007; 83–93.
Colosimo C , Inghilleri M , Ray Chaudhuri K. Parkinson's disease misdiagnosed as multiple system atrophy by sphincter electromyography. J Neurol 2000; 247: 559–61.
Colosimo C , Merello M , Pontieri FE. Amantadine in parkinsonian patients unresponsive to levodopa: a pilot study. J Neurol 1996; 243(5): 422–5.
Colosimo C , Merello M , Pontieri FE. Amantadine in parkinsonian patients unresponsive to levodopa: a pilot study. J Neurol 1996; 243: 422–5.
Colosimo C , Osaki Y , Vanacore N , et al. Lack of association between progressive supranuclear palsy and arterial hypertension: a clinicopathological study. Mov Disord 2003; 18: 694–7.
Colosimo C. Pisa syndrome in a patient with multiple system atrophy. Mov Disord 1998; 13(3): 607–9.
Colosimo C. Pisa syndrome in a patient with multiple system atrophy. Mov Disord 1998; 13: 607–9.
Combarros O , Infante J , Llorca , et al. Interleukin-1A (-889) genetic polymorphism increases the risk of multiple system atrophy. Mov Disord 2003; 18: 1385–6.
Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology 1996; 46: 1470.
Constantinescu R , Leonard C , Deeley C , et al. Assistive devices for gait in Parkinson's disease. Parkinsonism Relat Disord 2007; 13(3): 133–8.
Cordivari C , Misra VP , Catania S , et al. Treatment of dystonic clenched fist with botulinum toxin. Mov Disord 2001; 16: 907–13.
Cortese L , Caligiuri MP , Williams R , et al. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia. J Clin Psychopharmacol 2008; 28(1): 69–73.
Coulier IM , de Vries JJ , Leenders KL . Is FDG-PET a useful tool in clinical practice for diagnosing corticobasal ganglionic degeneration? Mov Disord 2003; 18: 1175–8.
Couper J. On the effects of black oxide of manganese when inhaled into the lungs. Br Ann Med Pharmacol 1837; 1: 41–2.
Courbon F , Brefel-Courbon C , Thalamas C , et al. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease. Mov Disord 2003; 18(8): 890–7.
Cousins DA , Burton EJ , Burn D , et al. Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer's disease. Neurology 2003; 61: 1191–5.
Cree BC , Bernardini GL , Hays AP , et al. A fatal case of coxsackievirus B4 meningoencephalitis. Arch Neurol 2003; 60(1): 107–12.
Critchley M. Arteriosclerotic parkinsonism. Brain 1929; 52: 23–83.
Critchley M. Arteriosclerotic parkinsonism. Brain 1929; 52: 23–83.
Crizzle AM , Newhouse IJ. Is physical exercise beneficial for persons with Parkinson's disease? Clin J Sport Med 2006; 16(5): 422–5.
Cubo E. [Movement disorders in adult-onset measles encephalitis]. Neurologia 2003; 18(1): 30–3.
Czlonkowska A , Rodo M , Gromadzka G. Late onset Wilson's disease: therapeutic implications. Mov Disord 2008; 23(6): 896–8.
da Costa Mdo D , Goncalves LR , Barbosa ER , et al. [Neuroimaging abnormalities in parkinsonism: study of five cases]. Arq Neuropsiquiatr 2003; 61(2B): 381–6.
da Costa Mdo D , Spitz M , Bacheschi LA , et al. Wilson's disease: two treatment modalities. Correlations to pretreatment and posttreatment brain MRI. Neuroradiology 2009; 51(10): 627–33.
da Silva CJ , da Rocha AJ , Jeronymo S , et al. A preliminary study revealing a new association in patients undergoing maintenance hemodialysis: manganism symptoms and T1 hyperintense changes in the basal ganglia. AJNR Am J Neuroradiol 2007; 28(8): 1474–9.
Dale RC , Church AJ , Surtees RA , et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain 2004; 127(1): 21–33.
Dale RC , Irani SR , Brilot F , et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol 2009; 66(5): 704–9.
Dallocchio C , Mazzarello P . A case of Parkinsonism due to lithium intoxication: treatment with Pramipexole. J Clin Neurosci 2002; 9(3): 310–1.
Daniel S. The neuropathology and neurochemistry of multiple system atrophy. In: Mathias CJ , Bartko JJ , eds. Autonomic failure. Oxford: Oxford University Press, 1999; 321–8.
Daniel SE , de Bruin V , Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 1995; 118: 759–70.
de la Fuente-Aguado J , Bordon J , Moreno JA , et al. Parkinsonism in an HIV-infected patient with hypodense cerebral lesion. Tuber Lung Dis 1996; 77(2): 191–2.
De Leo V , Morgante G , Musacchio MC , et al. The safety of veralipride. Expert Opin Drug Saf 2006; 5(5): 695–701.
de Mari M , De Blasi R , Lamberti P , et al. Unilateral pallidal lesion after acute disulfiram intoxication: a clinical and magnetic resonance study. Mov Disord 1993; 8(2): 247–9.
de Rosso AL , de Mattos JP , Correa RB , et al. Parkinsonism and AIDS: a clinical comparative study before and after HAART. Arq Neuropsiquiatr 2009; 67(3B): 827–30.
Deahl M. Betel nut-induced extrapyramidal syndrome: an unusual drug interaction. Mov Disord 1989; 4(4): 330–2.
Dean CE , Kuskowski MA , Caligiuri MP. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions. J Clin Psychopharmacol 2006; 26(6): 560–5.
Deane KH , Ellis-Hill C , Jones D , et al. Systematic review of paramedical therapies for Parkinson's disease. Mov Disord 2002; 17(5): 984–91.
Defebvre L. Myoclonus and extrapyramidal diseases. Neurophysiol Clin 2006; 36: 319–25.
Dejerine J , Thomas A. L'atrophie olivo-pontocerebelleuse. Nouvelle iconographie de la Salpetriere: Clinique des malacies du systeme nerveux 1900; 13: 330–70.
Del Ser T , McKeith IG , Anand R , et al. Dementia with Lewy bodies: findings from an international multicentre study. Int J Geriatr Psychiatry 2001; 15: 1034–45.
Demarquay G , Setiey A , Morel Y , et al. Clinical report of three patients with hereditary hemochromatosis and movement disorders. Mov Disord 2000; 15(6): 1204–9.
Demirkiran M , Bozdemir H , Sarica Y. Vascular parkinsonism: a distinct, heterogeneous clinical entity. Acta Neurol Scand 2001; 104: 63–7.
Deng H , Le WD , Jankovic J . Genetic study of an American family with DYT3 dystonia (lubag). Neurosci Lett 2008; 448(2): 180–3.
DePold Hohler A , Ransom BR , Chun MR , et al. The youngest reported case of corticobasal degeneration. Parkinsonism Relat Disord 2003; 10: 47–50.
Deuschl G , Bain P , Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 1998; 13: 2–23.
Dewey RJ, O ' Suilleabhain P. Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease. Neurology 2000; 55: 1753–4.
Di Filippo M , Tambasco N , Muzi G , et al. Parkinsonism and cognitive impairment following chronic exposure to potassium cyanide. Mov Disord 2008; 23(3): 468–70.
Di Maria E , Tabaton M , Vigo T , et al. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol 2000; 47: 374–7.
Diaz-Corrales FJ , Sanz-Viedma S , Garcia-Solis D , et al. Clinical features and 123I-FP-CIT SPECT imaging in drug-induced parkinsonism and Parkinson's disease. Eur J Nucl Med Mol Imaging 2010: 37(3): 556–64.
Dickson DW , Bergeron C , Chin SS , et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002; 61(11): 935–46.
Dickson DW , Bergeron C , Chin SS , et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002; 61: 935–46.
Dickson DW , Lin W , Liu WK , et al. Multiple system atrophy: a sporadic synucleinopathy. Brain Pathol 1999; 9: 721–32.
Dickson DW , Litvan I. Corticobasal degeneration. In: Dickson D , ed. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. Basel: Neuropath Press, 2003; 115–23.
Dickson DW. Tau and synuclein and their role in neuropathology. Brain Pathol 1999; 9: 657–61.
Dodel R , Spottke A , Gerhard A , et al. Minocycline 1 Year Therapy in Multiple-System-Atrophy: Effect on Clinical Symptoms and [11C] (R)-PK11195 PET (MEMSA-Trial). Mov Disord 2010; 25(1): 97–107.
Dolendo MC , Lin TP , Tat OH , et al. Parkinsonism as an unusual presenting symptom of pineal gland teratoma. Pediatr Neurol 2003; 28(4): 310–12.
Doody RS , Jankovic J. The alien hand and related sign. J Neurol Neurosurg Psychiatry 1999; 55 : 806–10.
Doran M , du Plessis DG , Enevoldson TP , et al. Pathological heterogeneity of clinically diagnosed corticobasal degeneration. J Neurol Sci 2003; 216: 127–34.
Dotti MT , Federico A. Amiodarone-induced parkinsonism: a case report and pathogenetic discussion. Mov Disor 1995; 10(2): 233–4.
Doty RL , Deems DA , Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage or disease duration. Neurology 1988; 38: 1237–44.
Doty RL , Golbe LI , McKeown DA , et al. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease. Neurology 1993; 43: 962–5.
Dubinsky RM , Jankovic J . Progressive supranuclear palsy and a multi-infarct state. Neurology 1987; 37(4): 570–6.
Duffy JR. Motor Speech Disorders. Substrates, differential diagnosis and management. St Louis: Elsevier Mosby, 2005.
Duron E , Lazareth A , Gaubert JY , et al. Gliomatosis cerebri presenting as rapidly progressive dementia and parkinsonism in an elderly woman: a case report. J Med Case Reports 2008; 2: 53.
Dworkin JP. Motor Speech Disorders. A Treatment Guide. St. Louis: Mosby – Year Book, Inc., 1991.
Ebersbach G , Sojet M , Valldeoriola F , et al. Comparative analysis of gait in Parkinson's disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy. Brain 1999; 122: 1349–55.
Ebihara S , Saito H , Kanda A , et al. Impaired efficacy of cough in patients with Parkinson disease. Chest 2003; 124(3): 1009–15.
Eckert T , Barnes A , Dhawan V , et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 2005; 26: 912–21.
Eckert T , Tang C , Ma Y , et al. Abnormal metabolic networks in atypical parkinsonism. Mov Disord 2008; 23: 727–33.
Eichhorn TE , Oertel WH. Macrogol 3350/electrolyte improves constipation in Parkinson's disease and multiple system atrophy. Mov Disord 2001; 16: 1176–7.
Eichhorn TE , Oertel WH. Macrogol 3350/electrolyte improves constipation in Parkinson's disease and multiple system atrophy. Mov Disord 2001; 16: 1176–7.
Eide PK , Sorteberg W . Diagnostic intracranial pressure monitoring and surgical management in idiopathic normal pressure hydrocephalus: a 6-year review of 214 patients. Neurosurgery 2010; 66(1): 80–91.
Eidelberg D , Takikawa S , Moeller JR , et al. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease. Ann Neurol 1993; 33(5): 518–27.
Ekinci B , Apaydin H , Vural M , et al. Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain 2007; 130(1): 110–19.
Ekinci B , Apaydin H , Vural M , et al. Two siblings with homocystinuria presenting with dystonia and parkinsonism. Mov Disord 2004; 19(8): 962–4.
Elizan TS , Hirano A , Abrams BM , et al. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam. Neurological reevaluation. Arch Neurol 1966; 14(4): 356–68.
Emre M , Aarsland D , Albanese A , et al. Rivastigmine for dementia associated with Parkinson's disease. N Eng J Med 2004; 351(24): 2509–18.
Emre M , Aarsland D , Albanese A , et al. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 2004; 351(24): 2509–18.
Emre M , Aarsland D , Brown R , et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22(12): 1689–707.
Emre M , Aarsland D , Brown R , et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22(12): 1689–707.
Emre M , Tsolaki M , Bonuccelli U , et al. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomized, double-blind, placebo-controlled trial. Lancet Neurol 2010; 9(10): 969–77.
Ertan S , Ulu MO , Hanimoglu H , et al. Phenytoin-induced parkinsonism. Singapore Med J 2006; 47(11): 981–3.
Espay AJ. Reversible parkinsonism and ataxia associated with high-dose octreotide. Neurology 2008; 70(24): 2345–6.
Esper CD , Factor SA . Failure of recognition of drug-induced parkinsonism in the elderly. Mov Disord 2008; 23(3): 401–4.
Estorch M , Camacho V , Paredes P , et al. Cardiac 123I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life. Eur J Nucl Med Mol Imaging 2008; 35: 1636–41.
Evans AH , Costa DC , Gacinovic S , et al. L-Dopa-responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings. Mov Disord 2004; 19(10): 1232–6.
Fabbrini G , Barbanti P , Bonifati V , et al. Donepezil in the treatment of progressive supranuclear palsy. Acta Neurol Scand 2001; 103: 123–5.
Fabiani G , Pastro PC , Froehner C . Parkinsonism and other movement disorders in outpatients in chronic use of cinnarizine and flunarizine. Arq Neuropsiquiatr 2004; 62(3B): 784–8.
Factor SA , Podskalny GD , Molho ES . Psychogenic movement disorders: frequency, clinical profile, and characteristics. J Neurol Neurosurg Psychiatry 1995; 59(4): 406–12.
Factor SA , Qian J , Lava NS , et al. False-positive SCA8 gene test in a patient with pathologically proven multiple system atrophy. Ann Neurol 2005; 57(3): 462–3.
Fahn S , Williams DT . Psychogenic dystonia. Adv Neurol 1988; 50: 431–55.
Federico P , Zochodne DW . Reversible parkinsonism and hyperammonemia associated with portal vein thrombosis. Acta Neurol Scand 2001; 103(3): 198–200.
Fergusson E , Howard R. Donepezil for the treatment of psychosis in dementia with Lewy bodies. Int J Geriatr Psychiatry 2000; 15: 280–1.
Ferman TJ , Boeve, BF , Smith GF , et al. Dementia with Lewy bodies may present as dementia and REM sleep behaviour disorder without parkinsonism or hallucinations. J Int Neuropsychol Soc 2002; 8: 907–14.
Ferman TJ , Smith GE , Boeve BF , et al. DLB fluctuations: specific features that reliably differentiate from AD and normal aging. Neurology 2004; 62: 252–6.
Fernagut PO , Diguet E , Stefanova N , et al. Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57B1/6 mice: Behavioural and histopathological characterisation. Neuroscience 2002; 114: 1005–17.
Ferrara J , Jankovic J . Acquired hepatocerebral degeneration. J Neurol 2009; 256(3): 320–32.
Fietta P , Manganelli P . Steroid-reversible parkinsonism as presentation of polymyalgia rheumatica. Clin Rheumatol 2006; 25(4): 564–5.
Finsterer J. Parkinson syndrome as a manifestation of mitochondriopathy. Acta Neurol Scand 2002; 105(5): 384–9.
Fitzgerald DB , Drago V , Jeong Y , et al. Asymmetrical alien hands in corticobasal degeneration. Mov Disord 2007; 22: 581–4.
FitzGerald PM , Jankovic J . Lower body parkinsonism: evidence for vascular etiology. Mov Disord 1989; 4(3): 249–60.
Foltynie T , Barker R , Brayne C. Vascular parkinsonism: a review of the precision and frequency of the diagnosis. Neuroepidemiology 2002; 21(1): 1–7.
Ford B , Louise P , Greene P , et al. Oral and genital pain syndromes in Parkinson's disease. Mov Disord 1996; 11: 421–6.
Forman MS , Lal D , Zhang B , et al. Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration. J Neurosci 2005; 25: 3539–50.
Formisano R , Cicinelli P , Buzzi MG , et al. Blink reflex changes in parkinsonism following severe traumatic brain injury correlates with diffuse axonal injury. Med Sci Monit 2009; 15(3): CR101–6.
Formisano R , Pratesi L , Modarelli FT , et al. Rehabilitation and Parkinson's disease. Scand J Rehabil Med 1992; 24(3): 157–60.
Fox JH , Bennett DA , Goetz CG , et al. Induction of parkinsonism by intraventricular bethanechol in a patient with Alzheimer's disease. Neurology 1989; 39(9): 1265.
Frank S , Clavaguera F , Tolnay M. Tauopathy models and human neuropathology: similarities and differences. Acta Neuropathol 2008; 115: 39–53.
Frattali CM , Grafman J , Patronas N , et al. Language disturbances in corticobasal degeneration. Neurology 2000; 54: 990–2.
Friedman JH , Ambler M. Progressive parkinsonism associated with Rosenthal fibers: senile-onset alexander's disease? Neurology 1992; 42(9): 1733–5.
Friess E , Kuempfel T , Modell S , et al. Paroxetine treatment improves motor symptoms in patients with multiple system atrophy. Parkinsonism Relat Disord 2006; 12: 432–7.
Frosini D , Ceravolo R , Rossi C , et al. Bilateral thalamic glioma presenting with parkinsonism. Mov Disord 2009; 24(14): 2168–9.
Frucht S , Fahn S , Chin S , et al. Levodopa-induced dyskinesias in autopsy-proven cortical-basal ganglionic degeneration. Mov Disord 2000; 15: 340–3.
Fuchs J , Nilsson C , Kachergus J , et al. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology 2007; 68: 916–22.
Fukunishi I , Kitaoka T , Shirai T , et al. A hemodialysis patient with trazodone-induced parkinsonism. Nephron 2002; 90(2): 222–3.
Furiya Y , Hirano M , Kurumatani N , et al. Alpha-1-antichymotrypsin gene polymorphism and susceptibility to multiple system atrophy (MSA). Brain Res Mol Brain Res 2005; 138: 178–81.
Furtado S , Payami H , Lockhart PJ , et al. Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2). Mov Disord 200; 19(6): 622–9.
Götz J , Tolnay M , Barmettler R , et al. Oligodendroglial tau filament formation in transgenic mice expressing G272V tau. Eur J Neurosci 2001; 13: 2131–40.
Gaig C , Marti MJ , Tolosa E , et al. Parkinsonism-hyperpyrexia syndrome not related to antiparkinsonian treatment withdrawal during the 2003 summer heat wave. J Neurol 2005; 252(9): 1116–19.
Galanaud JP , Elbaz A , Clavel J , et al. Cigarette smoking and Parkinson's disease: a case-control study in a population characterized by a high prevalence of pesticide exposure. Mov Disord 2005; 20: 181–9.
Gao X , Chen H , Schwarzschild MA , et al. Erectile dysfunction and the risk of Parkinson's disease. Am J Epidemiol 2007; 166: 1446–50.
Garbutt S , Matlin A , Hellmuth J , et al. Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease. Brain 2008; 131: 1268–81.
Garbutt S , Riley DE , Kumar AN , et al. Abnormalities of optokinetic nystagmus in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2004; 75: 1386–94.
Garcia-Estevez DA. [Delayed anoxic-ischaemic encephalopathy: a case of Parkinsonism secondary to anaphylactic shock]. Rev Neurol 2009; 48(5): 271–2.
Garcia-Moreno JM , Chacon-Pena J. Hypothyroidism and Parkinson's disease and the issue of diagnostic confusion. Mov Disord 2003; 18(9): 1058–9.
Garcia-Ruiz PJ , Javier Jimenez-Jimenez F , Garcia de Yebenes J. Calcium channel blocker-induced parkinsonism: clinical features and comparisons with Parkinson's disease. Parkinsonism Relat Disord 1998; 4(4): 211–214.
Gash DM , Rutland K , Hudson NL , et al. Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity. Ann Neurol 2008; 63(2): 184–92.
Gass J , Cannon A , Mackenzie IR , et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 2006; 15: 2988–3001.
Geevasinga N , Richards FH , Jones KJ , et al. Juvenile Huntington disease. J Paediatr Child Health 2006; 42(9): 552–4.
Gelb DJ , Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56: 33–9.
Geldmacher DS. Dementia with Lewy bodies: diagnosis and clinical approach. Cleve Clin J Med 2004; 71: 789–800.
Gerhard A , Banati RB , Goerres GB , et al. [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology 2003; 61(5): 686–9.
Gerhard A , Watts J , Trender-Gerhard I , et al. In vivo imaging of microglial activation with [11C](R)-PK 11195 PET in corticobasal degeneration. Mov Disord 2004; 19: 1221–6.
Geser F , Wenning GK , Poewe W , et al. How to diagnose dementia with Lewy bodies: state of the art. Mov Disord 2005; 20(Suppl 12): 11–20.
Geser F , Wenning GK , Seppi K , et al. Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG). Mov Disord 2006; 21(2): 179–86.
Ghaemi K , Krauss JK , Nakamura M . Hemiparkinsonism due to a pontomesencephalic cavernoma: improvement after resection. Case report. J Neurosurg Pediatr 2009; 4(2): 143–6.
Ghika J , Bogousslavsky J. Presymptomatic hypertension is a major feature in the diagnosis of progressive supranuclear palsy. Arch Neurol 1997; 54: 1104–8.
Ghika J , De Tribolet N , Regli F , et al. L-dopa resistant parkinsonism in an adult woman with a cyst in the posterior fossa. Schweiz Arch Neurol Psychiatr 1993; 144(5): 475–80.
Ghorayeb I , Bioulac B , Tison F. Sleep disorders in multiple system atrophy. J Neural Transm 2005; 112: 1669–75.
Ghorayeb I , Bioulac B , Tison F. Sleep disorders in multiple system atrophy. J Neural Transm 2005; 112: 1669–75.
Gibb WR , Luthert PJ , Marsden CD. Corticobasal degeneration. Brain 1989; 112: 1171–92.
Gibbons CH , Freeman R . Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance. Neurology 2006; 67: 28–32.
Gillespie LD , Gillespie WJ , Robertson MC , et al. Interventions for preventing falls in elderly people. Cochrane Database Syst Rev 2003; 4: CD000340.
Gillman MA , Sandyk R. Parkinsonism induced by a monoamine oxidase inhibitor. Postgrad Med J 1986; 62(725): 235–6.
Gilman S , Koeppe RA , Junck L , et al. Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy. Ann Neurol 1994; 36(2): 166–75.
Gilman S , Low P , Quinn N , et al. Consensus statement on the diagnosis of multiple system atrophy. Clin Auton Res 1998; 8: 359–62.
Gilman S , Low P , Quinn N , et al. Consensus statement on the diagnosis of multiple system atrophy. Clin Auton Res 1998; 8: 359–62.
Gilman S , Low PA , Quinn N , et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999; 163: 94–8.
Gilman S , May SJ , Shults CW , et al. The North American Multiple System Atrophy Study Group. J Neural Transm 2005; 112: 1687–94.
Gilman S , Sima AA , Junck L , et al. Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions. Ann Neurol 1996; 39: 241–55.
Gilman S , Wenning GK , Low PA , et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71(9): 670–6.
Gilman S , Wenning GK , Low PA , et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71(9): 670–6.
Gilman S. Functional imaging with positron emission tomography in multiple system atrophy. J Neural Transm 2005; 112(12): 1647–55.
Giray S , Sarica FB , Sen O , et al. Parkinsonian syndrome associated with subacute subdural haematoma and its effective surgical treatment: a case report. Neurol Neurochir Pol 2009; 43(3): 289–92.
Gitlin LN , Hauck WW , Dennis MP , et al. Maintenance of effects of the home environmental skill-building program for family caregivers and individuals with Alzheimer's disease and related disorders. J Gerontol A Biol Sci Med Sci 2005; 60(3): 368–74.
Gitlin LN , Winter L , Corcoran M , et al. Effects of the home environmental skill-building program on the caregiver-care recipient dyad: 6-month outcomes from the Philadelphia REACH Initiative. Gerontologist 2003; 43(4): 532–46.
Gjerris F. Transitory procaine-induced Parkinsonism. J Neurol Neurosurg Psychiatry 1971; 34(1): 20–2.
Goetz CG , Leurgans S , Lang AE , et al. Progression of gait, speech and swallowing deficits in progressive supranuclear palsy. Neurology 2003; 60(6): 917–22.
Goetz CG , Tanner CM , Klawans HL . The pharmacology of olivopontocerebellar atrophy. Adv in Neurol 1984; 41: 143–8.
Goetz CG. An early photographic case of probable progressive supranuclear palsy. Mov Disord 1996; 11: 617–8.
Goizet C , Boukhris A , Mundwiller E , et al. Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Hum Mutat 2009; 30(2): E376–85.
Goker-Alpan O , Giasson BI , Eblan MJ , et al. Glucocerebrosidase mutations are an important risk factor for Lewy body disorders. Neurology 2006; 67(5): 908–10.
Goker-Alpan O , Giasson BI , Eblan MJ , et al. Glucocerebrosidase mutations are an important risk factor for Lewy body disorders. Neurology 2006; 67: 908–10.
Goker-Alpan O , Schiffmann R , LaMarca ME , et al. Parkinsonism among Gaucher disease carriers. J Med Genet 2004; 41(12): 937–40.
Golbe LI , Davis PH. Progressive supranuclear palsy. In: Jankovic J , Tolosa E , eds. Parkinson's disease and movement disorders. Baltimore: Williams and Wilkins, 1993; 145–61.
Golbe LI , Di Iorio G , Sanges G , et al. Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Ann Neurol 1996; 40: 767–75.
Golbe LI , Ohman-Strickland PA. A clinical rating scale for progressive supranuclear palsy. Brain 2007; 130: 1552–65.
Golbe LI. Progressive supranuclear palsy. In: Beal M Flint , Lang AE , Ludolph A , eds. Neurodegenerative diseases. Cambridge: Cambridge University Press, 2005; 663–81.
Goldstein DS , Holmes C , Cannon RO 3rd, et al. Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 1997; 336(10): 696–702.
Goldstein DS. Dysautonomia in Parkinson's disease: neurocardiological abnormalities. Lancet Neurol 2003; 2: 669–76.
Goldstein DS. Orthostatic hypotension as an early finding in Parkinson's disease. Clin Auton Res 2006; 16: 46–54.
Gordon M , Gordon AS . Perhexiline maleate as a cause of reversible parkinsonism and peripheral neuropathy. J Am Geriatr Soc 1981; 29(6): 259–62.
Gouider-Khouja N , Vidaihet M , Bonnet AM , et al. Pure striatonigral degeneration and Parkinson's disease: a comparative clinical study. Mov Disord 1995; 10: 288–94.
GrÖschel K , Hauser TK , Luft A , et al. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Neuroimage 2004; 21: 714–24.
Graff MJ , Vernooij-Dassen MJ , Thijssen M , et al. Community based occupational therapy for patients with dementia and their care givers: randomised controlled trial. BMJ 2006; 333(7580): 1196.
Graham JG , Oppenheimer DR . Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969; 32(1): 28–34.
Graham JG , Oppenheimer DR . Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969; 32(1): 28–34.
Graham NL , Bak T , Patterson K , et al. Language function and dysfunction in corticobasal degeneration. Neurology 2003; 61: 493–9.
Graham NL , Bak T , Patterson K , et al. Language function and dysfunction in corticobasal degeneration. Neurology 2003; 61: 493–9.
Graham NL , Bak TH , Hodges JR. Corticobasal degeneration as a cognitive disorder. Mov Disord 2003; 18: 1224–32.
Gralewicz S , Dyzma M . Organic solvents and the dopaminergic system. Int J Occup Med Environ Health 2005; 18(2): 103–13.
Granalingham KK , Byrne EJ , Thornton A. Clock-face drawing to differentiate Lewy body and Alzheimer type dementia syndromes. Lancet 1996; 347: 696–7.
Grandas F , Lopez- Manzanares L . Bupropion-induced parkinsonism. Mov Disord 2007; 22(12): 1830–1.
Gregg RG , Metzenberg AB , Hogan K , et al. Waisman syndrome, a human X-linked recessive basal ganglia disorder with mental retardation: localization to Xq27.3-qter. Genomics 1991; 9(4): 701–6.
Grimes DA , Bergeron CB , Lang AE. Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration. Mov Disord 1999; 14: 674–80.
Grimes DA , Lang AE , Bergeron CB. Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 1999; 53: 1969–74.
Grosse P , Kühn A , Cordivari C , et al. Coherence analysis in the myoclonus of corticobasal degeneration. Mov Disord 2003; 18: 1345–50.
Hageman G , van der Hoek J , van Hout M , et al. Parkinsonism, pyramidal signs, polyneuropathy, and cognitive decline after long-term occupational solvent exposure. J Neurol 1999; 246(3): 198–206.
Halaska M , Ralph G , Wiedemann A , et al. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability. World J Urol 2003; 20: 392–9.
Halliday GM , Macdonald V , Henderson JM. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease. Brain 2005; 128: 2272–80.
Halperin A , Eistein D, Zimran A. Increased incidence of Parkinson disease among relatives of patients with Gaucher disease. Blood Cells Mol Dis 2006; 36(3): 426–8.
Halpern C , McMillan C , Moore P , et al. Calculation impairment in neurodegenerative diseases. J Neurol Sci 2003; 208: 31–8.
Handler CE , Besse CP , Wilson AO . Extrapyramidal and cerebellar syndrome with encephalopathy associated with cimetidine. Postgrad Med J 1982; 58(682): 527–8.
Hanna PA , Jankovic J , Kirkpatrick JB. Multiple system atrophy: the putative causative role of environmental toxins. Arch Neurol 1999; 56: 90–4.
Hansen L , Salmon D , Galasko D , et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 1990; 40(1): 1–8.
Hara K , Momose Y , Tokiguchi S , et al. Multiplex families with multiple system atrophy. Arch Neurol 2007; 64: 545–51.
Harding AJ , Broe GA , Halliday GM . Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002; 125: 391–403.
Harding AJ , Das A , Kril JJ , et al. Identification of families with cortical Lewy body disease. Am J Med Genet B Neuropsychiatr Genet 2004; 28: 118–22.
Haruta S , Manome T , Oguchi K , et al. [Hemiparkinsonism, probably due to malaria (author's transl)]. Rinsho Shinkeigaku 1978; 18(2): 103–7.
Hashimoto M , Rockenstein E , Mante M , et al. Beta-synuclein inhibits α-synuclein aggregation: a possible role as an antiparkinsonian factor. Neuron 2001; 32: 213–23.
Hasselblatt M , FÖllinger S , Steinbach P , et al. Corticobasal degeneration presenting with progressive spasticity. Neurology 2007; 68: 791–2.
Hassin-Baer S , Levy Y , Langevitz P , et al. Anti-beta2-glycoprotein I in Sjogren's syndrome is associated with parkinsonism. Clin Rheumatol 2007; 26(5): 743–7.
Hauw JJ , Daniel SE , Dickson D , et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994; 44: 2015–9.
Hawkes CH , Shephard BC. Olfactory evoked responses and identification tests in neurological disease. Ann NY Acad Sci 1998; 855: 608–15.
Heinz A , Wöhrle J , Schöls L , et al. Continuous subcutaneous lisuride infusion in OPCA. J Neural Transm Gen Sect 1992; 90(2): 145–50.
Hensiek AE , Bhatia K , Hawkes CH. Olfactory function in drug-induced parkinsonism. J Neurol 2000; 247: P303.
Higuchi M , Ishihara T , Zhang B , et al. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Neuron 2002; 35: 433–46.
Ho AK , Iansek R , Marigliani C , et al. Speech impairment in a large sample of patients with Parkinson's disease. Behav Neurol 1998; 11(3): 131–7.
Ho BL , Lieu AS , Hsu CY . Hemiparkinsonism secondary to an infiltrative astrocytoma. Neurologist 2008; 14(4): 258–61.
Hodges JR , Davies RR , Xuereb JH , et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol 2004; 56: 399–406.
Hoehn MM , Yahr MD . Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427–42.
Holdorrf B. Friedreich Heinrich Lewy (1885–1950) and his work. J Hist Neurosci 2002; 11: 19–28.
Holmberg B , Johansson JO , Poewe W , et al. Safety and tolerability of growth hormone therapy in multiple system atrophy: a double-blind, placebo-controlled study. Mov Disord 2007; 22(8): 1138–44.
Holmberg B , Johnels B , Ingvarsson P , et al. CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes. Parkinsonism Relat Disord 2001; 8: 23–31.
Holmberg B , Kallio M , Johnels B , et al. Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of parkinsonian syndromes. Mov Disord 2001; 16: 217–25.
Holmberg B , Rosengren L , Karlsson JE , et al. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease. Mov Disord 1998; 13: 70–7.
Hoogenraad T. Clinical manifestation. In: Hoogenraad T, ed. Wilson's disease. London: WB Saunders, 1996; 71–108.
Horimoto Y , Matsumoto M , Akatsu H , et al. Autonomic dysfunctions in dementia with Lewy bodies. J Neurol 2003; 250: 530–3.
Horvath R , Kley RA , Lochmüller H, et al. Parkinson syndrome, neuropathy, and myopathy caused by the mutation A8344G (MERRF) in tRNALys. Neurology 2007; 68(1): 56–8.
Houghton DJ , Litvan I. Unraveling progressive supranuclear palsy: from the bedside back to the bench. Parkinsonism Relat Disord 2007; 13(Suppl 3): S341–346.
Houlden H , Baker M , Morris HR , et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 2001; 56(12): 1702–6.
Houlden H , Baker M , Morris HR , et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 2001; 56: 1702–6.
Huang CC , Yen TC , Shih TS , et al. Dopamine transporter binding study in differentiating carbon disulfide induced parkinsonism from idiopathic parkinsonism. Neurotoxicology 2004; 25(3): 341–7.
Huang CC. Parkinsonism induced by chronic manganese intoxication – an experience in Taiwan. Chang Gung Med J 2007; 30(5): 385–95.
Huang YC , Lyu RK , Chen ST , et al. Parkinsonism in a patient with antiphospholipid syndrome – case report and literature review. J Neurol Sci 2008; 267(1–2): 166–9.
Huber FM , Bour F , Sazdovitch V , et al. Creutzfeldt–Jakob disease with slow progression. A mimickry of progressive supranuclear palsy. Bull Soc Sci Med Grand Duche Luxemb 2007; (2): 125–30.
Huckabee ML , Pelletier CA. Management of Adult Neurogenic Dysphagia. New York: Thomson Delmar Learning, 2003.
Hughes AJ , Daniel SE , Ben Shlomo Y , et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002; 125: 861–70.
Hughes AJ , Daniel SE , Ben-Shlomo Y , et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002; 125: 861–70.
Hughes AJ , Daniel SE , Ben-Shlomo Y , et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder sevice. Brain 2002; 125: 861–70.
Hughes AJ , Daniel SE , Blankson S , et al. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993; 50(2): 140–8.
Hughes AJ , Daniel SE , Blankson S , et al. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993; 50: 140–8.
Hunker CJ , Abbs JH. Uniform frequency of parkinsonian resting tremor in the lips, jaw, tongue, and index finger. Mov Disord 1990; 5: 71–7.
Hunter PC , Crameri J , Austin S , et al. Response of parkinsonian swallowing dysfunction to dopaminergic stimulation. J Neurol Neurosurg Psychiatry 1997; 63(5): 579–83.
Hussain IF , Brady CM , Swinn MJ , et al. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry 2001; 71: 371–4.
Hutchinson M , Fazzini E . Cholinesterase inhibition in Parkinson's disease. J Neurol Neurosurg Psychiatry 1996; 61(3): 324–5.
Ibanez P , Bonnet AM , Debarges B , et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 2004; 364: 1169–71.
Ickenstein GW , Klotz JM , Langohr HD . [Virus encephalitis with symptomatic Parkinson syndrome, diabetes insipidus and panhypopituitarism]. Fortschr Neurol Psychiatr 1999; 67(10): 476–81.
Imai H , Narabayashi H , Sakata E. “Pure akinesia” and the later added supranuclear ophthalmoplegia. Adv Neurol 1987; 45: 207–12.
Infante J , Llorca J , Berciano J , et al. Interleukin-8, intercellular adhesion molecule-1 and tumour necrosis factor-alpha gene polymorphisms and the risk for multiple system atrophy. J Neurol Sci 2005; 228: 11–13.
Inoue M , Yagishita S , Ryo M , et al. The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems. Acta Neuropathol (Berl) 1997; 93: 585–91.
Inoue N. [Extrapyramidal syndrome induced by chemical substances]. Nippon Rinsho 1993; 51(11): 2924–8.
Inzelberg R , Korczyn AD . Parkinsonism in adult-onset GM2 gangliosidosis. Mov Disord 1994; 9(3): 375–7.
Iranzo A , Santamaria J , Tolosa E , et al. Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy. Neurology 2004; 63: 930–2.
Iseki E , Togo T , Susuki K , et al. Dementia with Lewy bodies from the perspective of tauopathy. Acta Neuropathol 2003; 105: 265–70.
Iseki E. Dementia with Lewy bodies: reclassification of pathological subtypes and boundary with Parkinson's disease or Alzheimer's disease. Neuropathology 2004; 24: 72–8.
Ishii K , Imamwa T , Sasaki M , et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology 1998; 51: 125–30.
Ishikawa, M. [Idiopathic normal pressure hydrocephalus – regarding the guideline in progress]. Nippon Rinsho 2004; 62 (Suppl): 290–4.
Ishizawa K , Komori T , Sasaki S , et al. Microglial activation parallels system degeneration in multiple system atrophy. J Neuropathol Exp Neurol 2004; 63: 43–52.
Iwasaki Y , Kinoshita M , Wakata N . [A case report of pyridostigmine induced parkinsonism]. Rinsho Shinkeigaku 1988; 28(6): 662–4.
Jain S , Dawson J , Quinn NP , et al. Occupational therapy in multiple system atrophy: a pilot randomized controlled trial. Mov Disord 2004; 19(11): 1360–4.
Jain S , Dawson J , Quinn NP , et al. Occupational therapy in multiple system atrophy: a pilot randomized controlled trial. Mov Disord 2004; 19: 1360–4.
Jamora D , Lim SH , Pan A , et al. Valproate-induced Parkinsonism in epilepsy patients. Mov Disord 2007; 22(1): 130–3.
Jankovic J , Gilden JL , Hiner BC , et al. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med 1993; 95: 38–48.
Jankovic J. Peripherally induced movement disorders. Neurol Clin 2009; 27(3): 821–32, vii.
Jansen C , van Swieten JC , Capellari S , et al. Inherited Creutzfeldt-Jakob disease in a Dutch patient with a novel five octapeptide repeat insertion and unusual cerebellar morphology. J Neurol Neurosurg Psychiatry 2009; 80(12): 1386–9.
Jaradeh S , Dyck PJ . Hereditary motor and sensory neuropathy with treatable extrapyramidal features. Arch Neurol 1992; 49(2): 175–8.
Jellinger KA , Seppi K , Wenning GK. Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord 2005; 20(Suppl 12): S29–36.
Jellinger KA . Neuropathological spectrum of synucleinopathies. Mov Disord 2003; 18(Suppl 6): S2–12.
Jellinger KA. p25alpha immunoreactivity in multiple system atrophy and Parkinson disease. Acta Neuropathol 2006; 112: 112.
Jenkins M , Hussain N , Lee D , et al. Reversible parkinsonism and MRI diffusion abnormalities in cortical venous thrombosis. Neurology 2001; 57(2): 364–6.
Jog MS , Lang AE . Chronic acquired hepatocerebral degeneration: case reports and new insights. Mov Disord 1995; 10(6): 714–22.
Johnston BT , Li Q , Castell JA , et al. Swallowing and esophageal function in Parkinson's disease. Am J Gastroenterol 1995; 90(10): 1741–6.
Joseph FG , Lammie GA , Scolding NJ . CNS lupus: a study of 41 patients. Neurology 2007; 69(7): 644–54.
Joseph FG , Scolding NJ . Neuro-Behcet's disease in Caucasians: a study of 22 patients. Eur J Neurol 2007; 14(2): 174–80.
Josephs KA , Dickson DW. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Mov Disord 2003; 18: 1018–26.
Josephs KA , Duffy JR , Strand EA , et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 2006; 129: 1385–98.
Josephs KA , Duffy JR. Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy. Curr Opin Neurol 2008; 21: 688–92.
Josephs KA , Petersen RC , Knopman DS , et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 2006; 66: 41–8.
Josephs KA , Tang-Wai DF , Edland SD , et al. Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. Arch Neurol 2004; 61: 1881–4.
Josephs KA , Whitwell JL , Dickson DW , et al. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging 2008; 29: 280–9.
Juncos JL , Hirsch EC , Malessa S , et al. Mesencephalic cholinergic nuclei in progressive supranuclear palsy. Neurology 1991; 41: 25–30.
Köllensperger M , Geser F , Ndayisaba JP , et al. Clinical presentation, diagnosis and management of MSA in Europe: data from the EMSA-SG registry. Mov Disord 2010 [E pub ahead of print].
Kühn AA , Grosse P , Holtz K , et al. Patterns of abnormal motor cortex excitability in atypical parkinsonian syndromes. Clin Neurophysiol 2004; 115: 1786–95.
Kagi G , Bhatia KP , Tolosa E . The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry 2010; 81(1): 5–12.
Kahle PJ , Neumann M , Ozmen L , et al. Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep 2002; 3: 583–8.
Kalf H , Sturkenboom I , Thijssen M , et al. Pursuing best practice in multidisciplinary care. EPNN J 2008; 14: 12–15.
Kalf JG , de Swart BJM , Bloem BR , et al. Guidelines for speech-language therapy in Parkinson's disease. Mov Disord 2008; 23: S328.
Kalf JG , de Swart BJM , Bonnier MWJ , et al. Logopedie bij de ziekte van Parkinson. Een richtlijn van de Nederlandse Vereniging voor Logopedie en Foniatrie. Woerden: NVLF/Uitgeverij LEMMA, 2008.
Kalf JG , de Swart BJM , Borm GF , et al. Prevalence and definition of drooling in Parkinson's disease: a systematic review. J Neurol 2009; 256(9): 1391–6.
Kalra S , Grosset DG , Benamer HT. Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review. Mov Disord 2010; 25(2): 149–56.
Kamm C , Healy DG , Quinn NP , et al. The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group. Brain 2005; 128: 1855–60.
Kamsma YPT , Brouwer WH , Lakke JPW. Training of compensational strategies for impaired gross motor skills in Parkinson's disease. Physiother Theory Pract 1995; 11: 209–29.
Kanemaru K , Mitani K , Yamanouchi H. Cerebrospinal fluid homovanillic acid levels are not reduced in early corticobasal degeneration. Neurosci Lett 1998; 245: 121–2.
Kang SY , Lee MH , Lee SK , et al. Levodopa-responsive parkinsonism in hereditary spastic paraplegia with thin corpus callosum. Parkinsonism Relat Disord 2004; 10(7): 425–7.
Kato N , Arai K , Hattori T. Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 2003; 210: 57–60.
Kato S , Nakamura H. Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: immunohistochemical and ultrastructural studies. Acta Neuropathol 1990; 79: 584–94.
Katsuse O , Iseki E , Arai T , et al. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol 2003; 106: 251–60.
Katsuse O , Iseki E , Marui W , et al. Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies. J Neurol Sci 2003; 211: 29–35.
Katzenschlager R , Cardozo A , Avila Cobo MA , et al. Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders. Mov Disord 2003; 18: 1123–31.
Katzenschlager R , Lees A. Olfaction and Parkinson's syndromes: its role in differential diagnosis. Curr Opin Neurol 2004; 17: 417–23.
Kaufmann H , Nahm K , Purohit D , et al. Autonomic failure as the initial presentation of Parkinson's disease and dementia with Lewy bodies. Neurology 2004; 28: 1093–5.
Kaufmann H , Saadia D , Voustianiouk A , et al. Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation 2003; 108: 724–8.
Keith-Rokosh J , Ang LC. Progressive supranuclear palsy: a review of co-existing neurodegeneration. Can J Neurol Sci 2008; 35: 602–8.
Kemp PM , Holmes C. Imaging in dementia with Lewy bodies: a review. Nucl Med Commun 2007; 28: 451–6.
Kenney C , Hunter C , Jankovic J . Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord 2007; 22(2): 193–7.
Kertesz A , Davidson W , Munoz DG. Clinical and pathological overlap between frontotemporal dementia, primary progressive aphasia and corticobasal degeneration: The Pick complex. Dement Geriatr Cogn Disord 1999; 10 (Suppl 1): 46–9.
Kertesz A , Martinez-Lage P , Davidson W , et al. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 2000; 55: 1368–75.
Kertesz A , McMonagle P , Blair M , et al. The evolution and pathology of frontotemporal dementia. Brain 2005; 128: 1996–2005.
Kertesz A , Munoz DG. Diagnostic controversies: is CBD part of the “pick complex”? Adv Neurol 2000; 82: 223–31.
Keus SH , Bloem BR , Hendriks EJ , et al. Evidence-based analysis of physical therapy in Parkinson's disease with recommendations for practice and research. Mov Disord 2007; 22(4): 451–60.
Keus SH , Bloem BR , Verbaan D , et al. Physiotherapy in Parkinson's disease: utilisation and patient satisfaction. J Neurol 2004; 251(6): 680–7.
Keus SH , Munneke M , Nijkrake MJ ,et al. Physical therapy in Parkinson's disease: evolution and future challenges. Mov Disord 2009; 24(1): 1–14.
Khan NL , Giunti P , Sweeney MG , et al. Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6). Mov Disord 2005; 20(9): 1115–19.
Khan NL , Giunti P , Sweeney MG , et al. Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6). Mov Disord 2005; 20: 1115–19.
Kholodilov NG , Neystat M , Oo TF , et al. Increased expression of rat synuclein1 in the substantia nigra pars compacta identified by differential display in a model of developmental target injury. J Neurochem 1999; 73: 2586–99.
Kiefer M , Meier U , Eymann R . Does idiopathic normal pressure hydrocephalus always mean a poor prognosis? Acta Neurochir Suppl 2010; 106: 101–6.
Kim JS , Choi IS , Lee MC . Reversible parkinsonism and dystonia following probable mycoplasma pneumoniae infection. Mov Disord 1995; 10(4): 510–12.
Kim MJ , Chung SJ , Sung YH , et al. Levodopa-responsive parkinsonism associated with hydrocephalus. Mov Disord 2006; 21(8): 1279–81.
Kim TW , Park IS , Kim SH , et al. Striopallidodentate calcification and progressive supranuclear palsy-like phenotype in a patient with idiopathic hypoparathyroidism. J Clin Neurol 2007; 3(1): 57–61.
Kimber JR , Watson L , Mathias CJ. Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine. Lancet 1997; 349: 1877–81.
Kinugawa K , Itti E , Lepeintre JF , et al. Subacute dopa-responsive Parkinsonism after successful surgical treatment of aqueductal stenosis. Mov Disord 2009; 24(16): 2438–40.
Kirchhof K , Apostolidis AN , Mathias CJ , et al. Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study. Int J Impot Res 2003; 15: 293–8.
Klaffke S , Kuhn AA , Plotkin M , et al. Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration. Mov Disord 2006; 21: 1724–7.
Kleiner-Fisman G , Bergeron C , Lang AE. Presentation of Creutzfeldt-Jakob disease as acute corticobasal degeneration syndrome. Mov Disord 2004; 19: 948–9.
Klos KJ , Bower JH , Josephs KA , et al. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord 2005; 11: 381–6.
Kluin K , Gilman S , Foster N , et al. Neuropathological correlates of dysarthria in progressive supranuclear palsy. Arch Neurol 2001; 58(2): 265–9.
Kluin KJ , Gilman S , Lohman M , et al. Characteristics of the dysarthria of multiple system atrophy. Arch Neurol 1996; 53(6): 545–8.
Kobylecki C , Sylverdale MA , Varma A , et al. HIV-associated Parkinsonism with levodopa-induced dyskinesia and response to highly-active antiretroviral therapy. Mov Disord 2009; 24(16): 2441–2.
Koellensperger M , Wenning KG . Parkinson Plus disorders. In: Therapeutics of Parkinson`s disease and other movement disorders. Hallet M , ed. Chichester: Wiley Blackwell, 2008; 157–274.
Kohlhaas K , Brechmann T , Vorgerd M. [Hepatitis B associated polyarteriitis nodosa with cerebral vasculitis]. Dtsch Med Wochenschr 2007; 132(34–35): 1748–52.
Kollensperger M , Seppi K , Liener C , et al. Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy. Mov Disord 2007; 22(12): 1771–6.
Kollensperger M , Stampfer-Kountchev M , Seppi K , et al. Progression of dysautonomia in multiple system atrophy: a prospective study of self-perceived impairment. Eur J Neurol 2007; 14(1): 66–72.
Kompoliti K , Goetz CG , Boeve BF , et al. Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol 1998; 55: 957–61.
Kompoliti K , Goetz CG , Boeve BF , et al. Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol 1998; 55: 957–61.
Konno H , Yamamoto T , Iwasaki Y , et al. Shy-Drager syndrome and amyotrophic lateral sclerosis. Cytoarchitectonic and morphometric studies of sacral autonomic neurons. J Neurol Sci 1986; 73: 193–204.
Korczyn AD. Autonomic nervous system disturbances in Parkinson's disease. Adv Neurol 1990; 53: 463–8.
Kornilova Z , Khokhlov Iu K , Savin AA , et al. [Clinical aspects, diagnosis and treatment of neurological complications of tuberculosis]. Probl Tuberk 2001; 3: 29–32.
Kosaka K , Yoshimura M , Ikeda K , et al. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree – a new disease? Clin Neuropathol 1984; 3(5): 185–92.
Kosaka K. Dementia and neuropathology in Lewy body disease. Adv Neurol 1993; 60: 456–63.
Kosaka K. Dementia and neuropathology in Lewy body disease. Adv Neurol 1993; 60: 456–63.
Kovacs GG , Gelpi E , Lehotzky A , et al. The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases. Acta Neuropathol 2007; 113: 153–61.
Kovacs T , Szirmai I , Papp M. [Clinico-pathology and differential diagnosis of Binswanger's disease]. Ideggyogy Sz 2005; 58(3–4): 78–87.
Koyama M , Yagishita A , Nakata Y , et al. Imaging of corticobasal degeneration syndrome. Neuroradiology 2007; 49: 905–12.
Kramer ML , Schulz-Schaeffer WJ . Presynaptic α-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 2007; 27: 1405–10.
Kraoua I , Stirnemann J , Ribeiro MJ , et al. Parkinsonism in Gaucher's disease type 1: ten new cases and a review of the literature. Mov Disord 2009; 24(10): 1524–30.
Krim E , Vital A , Macia F , et al. Atypical parkinsonism combining alpha-synuclein inclusions and polyglucosan body disease. Mov Disord 2005; 20(2): 200–4.
Kruger R , Kuhn W , Leenders KL , et al. Familial parkinsonism with synuclein pathology: clinical and PET studies of A30P mutation carriers. Neurology 2001; 56: 1355–62.
Kuloglu M , Caykoylu A , Ekinci O , et al. Successful management of depression with reboxetine in a patient who developed parkinsonism related to paroxetine use. J Psychopharmacol 2010; 24(4): 623–4.
Kumar R , Bergeron C , Pollanen M , et al. Cortical-basal Ganglionic Degeneration. In: Jankovic J , Tolosa E , eds. Parkinson's Disease and Movement Disorders. Baltimore: Williams and Wilkins, 1998; 297–316.
Kume A , Takahashi A , Hashizume Y, et al. Neuronal cell loss of the striatonigral system in multiple system atrophy. J Neurol Sci 1993; 117: 33–40.
Kuoppamaki M , Rothwell JC , Brown RG , et al. Parkinsonism following bilateral lesions of the globus pallidus: performance on a variety of motor tasks shows similarities with Parkinson's disease. J Neurol Neurosurg Psychiatry 2005; 76(4): 482–90.
Kuzuhara S , Kokubo Y . Atypical parkinsonism of Japan: amyotrophic lateral sclerosis-parkinsonism-dementia complex of the Kii peninsula of Japan (Muro disease): an update. Mov Disord 2005; 20(Suppl 12): S108–13.
Kwon KY , Choi CG , Kim JS , et al. Comparison of brain MRI and 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease. Mov Disord 2007; 22(16): 2352–8.
López de Munain A , Alzualde A , Gorostidi A , et al. Mutations in progranulin gene: clinical, pathological, and ribonucleic acid expression findings. Biol Psychiatry 2008; 63: 946–52.
López IC , Bermejo PG , Espiga PJ , et al. [L-dopa sensitive Parkinsonism in neurocysticercosis]. Neurologia 2008; 23(2): 119–21.
Lagalla G , Millevolte M , Capecci M , et al. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Mov Disord 2006; 21: 704–7.
Lambon RMA , Powell J , Howard D , et al. Semantic memory is impaired in both dementia with Lewy bodies and dementia of Alzheimer type: a comparative neuropsychological study and literature review. J Neurol Neurosurg Psychiatry 2001; 70: 149–56.
Lanctot KL , Herrmann N. Donepezil for behavioural disorders associated with Lewy bodies: a case series. Int J Geriatr Psychiatry 2000; 15: 338–45.
Landes AM , Sperry SD , Strauss ME , et al. Apathy in Alzheimer's disease. J Am Geriatr Soc 2001; 49(12): 1700–7.
Lang AE , Bergeron C , Pollanen MS , et al. Parietal Pick's disease mimicking cortical-basal ganglionic degeneration. Neurology 1994; 44(8): 1436–40.
Lang AE , Bergeron C , Pollanen MS , et al. Parietal Pick's disease mimicking cortical-basal ganglionic degeneration. Neurology 1994; 44: 1436–40.
Lang AE , Koller WC , Fahn S . Psychogenic parkinsonism. Arch Neurol 1995; 52(8): 802–10.
Lang AE , Lozano A , Duff J , et al. Medial pallidotomy in late-stage Parkinson's disease and striatonigral degeneration. Adv Neurol 1997; 74: 199–211.
Lang AE. Treatment of progressive supranuclear palsy and corticobasal degeneration. Mov Disord 2005; 20 (Suppl 12): S83–91.
Lange KW , Tucha O , Alders GL , et al. Differentiation of parkinsonian syndromes according to differences in executive functions. J Neural Transm 2003; 110: 983–95.
Langston JW , Ballard P , Tetrud JW , et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983; 219(4587): 979–80.
Lannuzel A , Hoglinger GU , Verhaeghe S , et al. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? Brain 2007; 130(3): 816–27.
Lantos PL. The definition of multiple system atrophy: a review of recent developments. J Neuropathol Exp Neurol 1998; 57: 1099–111.
Laplane D , Attal N , Sauron B , et al. Lesions of basal ganglia due to disulfiram neurotoxicity. J Neurol Neurosurg Psychiatry 1992; 55(10): 925–9.
Laureys S , Salmon E , Garraux G , et al. Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration. J Neurol 1999; 246: 1151–8.
Le Ber I , Camuzat A , Hannequin D , et al. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain 2008; 131: 732–46.
Lee MS , Kim YD , Lyoo CH. Oculogyric crisis as an initial manifestation of Wilson's disease. Neurology 1999; 52: 1714–5.
Lee PH , Yeo SH , Yong SW , et al. Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism. J Neurol Neurosurg Psychiatry 2007; 78(11): 1250–2.
Lee VM , Giasson BI , Trojanowski JQ . More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases. Trends Neurosci 2004; 27(3): 129–34.
Lee WY , Jin DK , Oh MR , et al. Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients. Arch Neurol 2003; 60: 858–63.
Lees AJ , Bannister R. The use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy–Drager syndrome). J Neurol Neurosurg Psychiatry 1981; 44(4): 347–51.
Lees AJ , Smith E. Cognitive deficits in Parkinson's disease. Brain 1983; 106: 257–70.
Lees AJ. The Steele–Richardson–Olszewski syndrome (progressive supranuclear palsy). In: Marsden CD , Fahn S , eds. Movement disorders 2. London: Butterworths, 1987; 272–87.
Lees AJ. The Steele–Richardson–Olszewski syndrome (progressive supranuclear palsy). In: Marsden CD , Fahn S , eds. Movement disorders 2. London: Butterworths, 1987; 272–87.
Leiguarda R , Lees AJ , Merello M , et al. The nature of apraxia in corticobasal degeneration. J Neurol Neurosurg Psychiatry 1994; 57: 455–9.
Leroi I , Brandt J , Reich SG , et al. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease. Int Geriatr Psychiatry 2004; 19(1): 1–8.
Lewy FH. Historical introduction: The basal ganglia and their disease. Trans Am Neurol Assoc 1942; 20: 1–20.
Lewy FH. Paralysis agitans I Pathologische Anatomie. In: Lewandowsky M , ed. Handbuch der Neurologie . Vol III. Berlin: Springer, 1912; 920–33.
Lezcano E , Gomez-Esteban JC , Zarranz JJ , et al. Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case report. Mov Disord 2004; 19: 973–7.
Lim SY , Wadia P, Wenning GK , et al. Clinically probable multiple system atrophy with predominant parkinsonism associated with myotonic dystrophy type 2. Mov Disord 2009; 24(9): 1407–9.
Lima MA , Maradei S , Maranhao Filho P . Cyclosporine-induced parkinsonism. J Neurol 2009; 256(4): 674–5.
Lin IS , Wu RM , Lee-Chen GJ , et al. The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment. Parkinsonism Relat Disord 2007; 13(4): 246–9.
Lincoln SJ , Ross OA , Milkovic NM , et al. Quantitative PCR-based screening of alpha-synuclein multiplication in multiple system atrophy. Parkinsonism Relat Disord 2007; 13: 340–2.
Lindersson E , Lundvig D , Petersen C , et al. p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies. J Biol Chem 2005 280: 5703–15.
Lipp A , Sandroni P , Ahlskog JE , et al. Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure. Arch Neurol 2009; 66: 742–50.
Lippa CF , Duda JE , Grossman M , et al. DLB and PDD boundary issues. Diagnosis, treatment, molecular pathology, and biomarkers. Neurology 2007; 68: 812–19.
Lippa CF , McKeith I. Dementia with Lewy bodies: improving diagnostic criteria. Neurology 2003; 60: 1571–2.
Litvan I , Agid Y , Calne D , et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome): report of the NINDS–SPSP international workshop. Neurology 1996; 47(1): 1–9.
Litvan I , Agid Y , Calne D , et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology 1996; 47: 1–9.
Litvan I , Bhatia KP , Burn DJ , et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003; 18(5): 467–86.
Litvan I , Bhatia KP , Burn DJ , et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003; 18: 467–86.
Litvan I , Campbell G , Mangone CA , et al. Which clinical features differentiate progressive supranuclear palsy from related disorders? A clinicopathological study. Brain 1997; 120: 65–74.
Litvan I , Cummings JL , Mega M. Neuropsychiatric features of corticobasal degeneration. J Neurol Neurosurg Psychiatry 1998; 65: 717–21.
Litvan I , Grimes DA , Lang AE , et al. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999; 246(Suppl 2): II1–5.
Litvan I , Grimes DA , Lang AE , et al. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999; 246(Suppl 2): II1–5.
Litvan I , MacIntyre A , Goetz CG , et al. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol 1998; 55(7): 969–78.
Litvan I , Mangone CA , McKee A , et al. Natural history of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996; 60(6): 615–20.
Litvan I , Mangone CA , McKee A , et al. Natural history of progressive supranuclear palsy (Steele–Richardson–Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996; 60(6): 615–20.
Litvan I , Sastry N , Sonies BC. Characterizing swallowing abnormalities in progressive supranuclear palsy. Neurology 1997; 48(6): 1654–62.
Liu F , Gong CX. Tau exon 10 alternative splicing and tauopathies. Mol Neurodegener 2008; 3: 8.
Liu Y , Stern Y , Chun MR , et al. Pathological correlates of extrapyramidal signs in Alzheimer's disease. Ann Neurol 1997; 41(3): 368–74.
LladÓ A , Sánchez-Valle R , Rey MJ , et al. Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration. J Neurol 2008; 255: 488–94.
Llau ME , Nguyen L , Senard JM , et al. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance]. Rev Neurol (Paris) 1994; 150(11): 757–62.
Lobotesis K , Fenwick JD , Phipps A , et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001; 56: 643–9.
Lopez-Alberola R , Georgiou M , Sfakianakis GN , et al. Contemporary Encephalitis Lethargica: phenotype, laboratory findings and treatment outcomes. J Neurol 2009; 256(3): 396–404.
Low PA , Gilden JL , Freeman R , et al. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA 1997; 277: 1046–51.
Lu CS , Chang HC , Kuo PC , et al. The parkinsonian phenotype of spinocerebellar ataxia type 3 in a Taiwanese family. Parkinsonism Relat Disord 2004; 10(6): 369–73.
Lu CS , Wu Chou YH , Kuo PC , et al. The parkinsonian phenotype of spinocerebellar ataxia type 2. Arch Neurol 2004; 61(1): 35–8.
Ludolph AC , Kassubek J , Landwehrmeyer BG , et al. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol 2009; 16(3): 297–309.
Luijckx GJ , Nieuwhof C , Troost J , et al. Parkinsonism in alcohol withdrawal: case report and review of the literature. Clin Neurol Neurosurg 1995; 97(4): 336–9.
Luoma P , Melberg A , Rinne JO , et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 2004; 364(9437): 875–82.
Müller J , Wenning GK , Jellinger K , et al. Progression of Hoehn and Yahr stages in parkinsonian disorders: a clinicopathologic study. Neurology 2000; 55: 888–91.
Machado A , Chien HF , Deguti MM , et al. Neurological manifestations in Wilson's disease. Mov Disord 2006; 21: 2192–6.
Mailliot C , Sergeant N , Bussière T , et al. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes. FEBS Lett 1998; 433(3): 201–4.
Mak MK , Hui-Chan CW. Audiovisual cues can enhance sit-to-stand in patients with Parkinson's disease. Mov Disord 2004; 19(9): 1012–19.
Mallucci GR , Campbell TA , Dickinson A , et al. Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene. Brain 1999; 122: 1823–37.
Mancini F , Zangaglia R , Cristina S , et al. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord 2003; 18: 685–8.
Manley TJ , Chusid MJ , Rand SD , et al. Reversible parkinsonism in a child after bone marrow transplantation and lipid-based amphotericin B therapy. Pediatr Infect Dis J 1998; 17(5): 433–4.
Manning-Bog AB , McCormack AL , Purisai MG , et al. Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration.J Neurosci 2003; 23: 3095–9.
Manyam BV , Walters AS , Narla KR . Bilateral striopallidodentate calcinosis: clinical characteristics of patients seen in a registry. Mov Disord 2001; 16(2): 258–64.
Manyam, B.V. What is and what is not “Fahr's disease.” Parkinsonism Relat Disord 2005; 11(2): 73–80.
Maraganore DM , Boeve B , Parisi J. Disorders mimicking the “classical” clinical syndrome of cortical-basal ganglionic degeneration. Mov Disord 1996; 11: 347.
Mark MH , Sage JI , Walters AS , et al. Binswanger disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases. Mov Disord 1995; 10: 450–4.
Markopoulou K , Larsen KW , Wszolek EK , et al. Olfactory dysfunction in familial parkinsonism. Neurology 1997; 49: 1262–7.
Marti Masso JF , Carrera N , Urtasun M . Drug-induced parkinsonism: a growing list. Mov Disord 1993; 8(1): 125.
Marti Masso JF , Marti I, Carrera N, et al. Trimetazidine induces parkinsonism, gait disorders and tremor. Therapie 2005; 60(4): 419–22.
Marui W , Iseki E , Nakai T , et al. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. J Neurol Sci 2002; 195: 153–9.
Masellis M , Momeni P , Meschino W , et al. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain 2006; 129: 3115–23.
Masmoudi K , Gras-Champel V , Douadi Y , et al. [Trimetazidine-a new aetiology for extrapyramidal disorders: A case of parkinsonism and akathisia]. Therapie 2005; 60(6): 603–5.
Mata IF , Samii A , Schneer SH , et al. Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. Arch Neurol 2008; 65(3): 379–82.
Mathias CJ , Fosbraey P , da Costa DF , et al. The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. Br Med J (Clin Res Ed) 1986; 293: 353–4.
Mathias CJ , Senard JM , Braune S , et al. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Clin Auton Res 2001; 11: 235–42.
Mathuranath PS , Xuereb JH , Bak T , et al. Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature. J Neurol Neurosurg Psychiatry 2000; 68: 304–12.
Matsuo A , Akiguchi I , Lee GC , et al. Myelin degeneration in multiple system atrophy detected by unique antibodies. Am J Pathol 1998; 153: 735–44.
Matsuo H , Matsui A , Nasu R , et al. Propiverine-induced Parkinsonism: a case report and a pharmacokinetic/pharmacodynamic study in mice. Pharm Res 2000; 17(5): 565–71.
Matsuo H , Takashima H , Kishikawa M , et al. Pure akinesia: an atypical manifestation of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1991; 54: 397–400.
Matsuoka Y , Jouroukhin Y , Gray AJ , et al. A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease. J Pharmacol Exp Ther 2008; 325: 146–53.
Mattos JP , Rosso AL , Correa RB , et al. Movement disorders in 28 HIV-infected patients. Arq Neuropsiquiatr 2002; 60(3-A): 525–30.
Matuska K , Mathiowetz V , Finlayson M. Use and perceived effectiveness of energy conservation strategies for managing multiple sclerosis fatigue. Am J Occup Ther 2007; 61(1): 62–9.
Matzler W , Nagele T , Gasser T , et al. Acute parkinsonism with corresponding lesions in the basal ganglia after heroin abuse. Neurology 2007; 68(6): 414.
May EF , Ling GS , Geyer CA , et al. Contrast agent overdose causing brain retention of contrast, seizures and parkinsonism. Neurology 1993; 43(4): 836–8.
McCrank E. Parkinsonism secondary to petroleum exposure. Neurology 1995; 45(11): 2112.
McKee AC , Cantu RC , Nowinski CJ , et al. Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 2009; 68(7): 709–35.
McKeith I , Del Ser T , Spano P , et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000; 356(9247): 2031–6.
McKeith I , Del Ser T , Spano P , et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000; 356: 2031–2036.
McKeith I , Fairbairn A , Perry R , et al. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. Br Med J 1992; 305: 673–8.
McKeith I , O'Brien J , Walker Z , et al. Sensitivity and specificity of dopaminergic transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies; a phase III multi-centre, prospective study. Lancet Neurol 2007; 6: 305–13.
McKeith IG , Ballard, CG , Perry RH , et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000; 10: 50–8.
McKeith IG , Burn D. Spectrum of Parkinson's disease, Parkinson's dementia and Lewy body dementia. In: DeKosky ST , ed. Neurologic Clinics. WB Saunders: Philadelphia, 2000; 865–83.
McKeith IG , Dickson DW , Lowe J , et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65 (12): 1863–72.
McKeith IG , Galasko D , Kosaka K , et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47(5): 1113–24.
McKeith IG , Galasko D , Kosaka K , et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB workshop. Neurology 1996; 47: 1113–24.
McKeith IG , Galasko D , Kosava K , et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies: report of the consortium on DLB international workshop. Neurology 1996; 47: 1113–24.
McKeith IG . Dementia with Lewy bodies and Parkinson's disease with dementia: where two worlds collide. Pract Neurol 2007; 7: 374–82.
McKeith, Dickson DW , Lowe J , et al. Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology 2005; 65: 1863–72.
McMonagle P , Blair M , Kertesz A. Corticobasal degeneration and progressive aphasia. Neurology 2006; 67: 1444–51.
Meara J , Bhowmick BK , Hobson P. Accuracy of diagnosis in patients with presumed Parkinson's disease. Age Ageing 1999; 28: 99–102.
Mehta SH , Morgan JC , Sethi KD . Paraneoplastic movement disorders. Curr Neurol Neurosci Rep 2009; 9(4): 285–91.
Mellick G , Price L , Boyle R . Late-onset presentation of pyruvate dehydrogenase deficiency. Mov Disord 2004; 19(6): 727–9.
Mellon AF , Appleton RE , Gardner-Medwin D , et al. Encephalitis lethargica-like illness in a five-year-old. Dev Med Child Neurol 1991; 33(2): 158–61.
Melquist S , Craig DW , Huentelman MJ , et al. Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. Am J Hum Genet 2007; 80: 769–78.
Mendez MF. Corticobasal ganglionic degeneration with Balint's syndrome. J Neuropsych Clin Neurosci 2000; 12: 273–5.
Mendez MF. Corticobasal ganglionic degeneration with Balint's syndrome. J Neuropsychiatry Clin Neurosci 2000; 12: 273–5.
Mendhekar DN , Benuiwal RP , Puri V. Parkinsonism and elevated lactic acid with sertraline. Can J Psychiatry 2005; 50(5): 301.
Meseguer E , Taboada R , Sanchez V , et al. Life-threatening parkinsonism induced by kava-kava. Mov Disord 2002; 17(1): 195–6.
Miao J , Su C , Wang W , et al. Delayed parkinsonism with a selective symmetric basal ganglia lesion after manual strangulation. J Clin Neurosci 2009; 16(4): 573–5.
Miller DD , Caroff SN , Davis SM , et al. Extrapyramidal side-effects of antipsychotics in a randomised trial. Br J Psychiatry 2008; 193(4): 279–88.
Miller DW , Johnson JM , Solano SM , et al. Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J Neural Transm 2005; 112: 1613–24.
Miller K , Ochudlo S , Opala G , et al. [Parkinsonism in chronic occupational metallic mercury intoxication]. Neurol Neurochir Pol 2003; 37(Suppl 5): 31–8.
Miller N , Noble E , Jones D , et al. Hard to swallow: dysphagia in Parkinson's disease. Age Ageing 2006; 35(6): 614–18.
Miller N , Noble E , Jones D , et al. Life with communication changes in Parkinson's disease. Age Ageing 2006; 35(3): 235–9.
Minoshima S , Foster NL , Sima AAF , et al. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 2001; 50: 358–65.
Mintz U , Liberman UA , de Vries A . Parkinsonism syndrome due to cephaloridine. JAMA 1971; 216(7): 1200.
Miric D , Nahum S , Jibidar H , et al. Vascular parkinsonism in an elderly woman with mixed cryoglobulinemia associated with hepatitis C infection. J Am Geriatr Soc 2006; 54(11): 1798.
Mirra SS , Murrell JR , Gearing M , et al. Tau pathology in a family with dementia and a P301L mutation in tau. J Neuropathol Exp Neurol 1999; 58: 335–45.
Misra UK , Kalita J. Prognosis of Japanese encephalitis patients with dystonia compared to those with parkinsonian features only. Postgrad Med J 2002; 78(918): 238–41.
Mitani K , Furiya Y , Uchihara T , et al. Increased total CSF tau protein in corticobasal degeneration has also been reported in patients with CBGD compared to normal controls. J Neurol 1998; 245: 44–6.
Miwa H , Hatori K , Kondon T , et al. Thalamic tremor: case reports and implications of the tremor-generating mechanisms. Neurology 1996; 46: 75–9.
Modestin J , Wehrli MV , Stephan PL , et al. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment. Schizophr Res 2008; 100(1–3): 97–107.
Modoni A , Contarino MF , Bentivoglio AR , et al. Prevalence of spinocerebellar ataxia type 2 mutation among Italian Parkinsonian patients. Mov Disord 2007; 22(3): 324–7.
Molina-Porcel L , Llado A , Rey MJ , et al. Clinical and pathological heterogeneity of neuronal intermediate filament inclusion disease. Arch Neurol 2008; 65(2): 272–5.
Molloy S , McKeith I , O'Brien J , et al. The role of levodopa in the management of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2005; 76(9): 1200–3.
Molloy S , Rowan EN , O'Brien JT , et al. Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2006; 77: 1323–8.
Montpetit V , Clapin DF , Guberman A. Substructure of 20 nm filaments of progressive supranuclear palsy. Acta Neuropathol 1985; 68: 311–18.
Monza D , Ciano C , Scaioli V , et al. Neurophysiological features in relation to clinical signs in clinically diagnosed corticobasal degeneration. Neurol Sci 2003; 24: 16–23.
Morfis L , Cordato DJ . Dementia with Lewy bodies in an elderly Greek male due to alpha-synuclein gene mutation. J Clin Neurosci 2006; 13: 942–4.
Morgan JT , Scumpia AJ , Webster TM , et al. Resting tremor secondary to a pineal cyst: case report and review of the literature. Pediatr Neurosurg 2008; 44(3): 234–8.
Morishita T , Foote KD , Okun MS. INPH and Parkinson disease: differentiation by levodopa response. Nat Rev Neurol 6(1): 52–6.
Morris HR , Janssen JC , Bandmann O , et al. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases. J Neurol Neurosurg Psychiatry 1999; 66: 665–7.
Morris HR , Moriabadi NF , Lees AJ , et al. Parkinsonism following electrical injury to the hand. Mov Disord 1998; 13(3): 600–2.
Morris HR , Osaki Y , Holton J , et al. Tau exon 10+16 mutation FTDP-17 presenting clinically as sporadic young onset PSP. Neurology 2003; 61: 102–4.
Morris HR , Vaughan JR , Datta SR , et al. Multiple system atrophy/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE. Neurology 2000; 55: 1918–20.
Morris ME. Locomotor training in people with Parkinson disease. Phys Ther 2006; 86(10): 1426–35.
Morris ME. Movement disorders in people with Parkinson disease: a model for physical therapy. Phys Ther 2000; 80(6): 578–97.
Morris MS , Iansek RN. Parkinson's disease: a team approach. Melbourne, Australia: Buscombe Vicprint, 1997.
Mridula KR , Alladi S , Varma DR , et al. Corticobasal syndrome due to a thalamic tuberculoma and focal cortical atrophy. J Neurol Neurosurg Psychiatry 2008; 79: 107–8.
Mueller A , Reuner U , Landis B , et al. Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction. Mov Disord 2006; 21: 1311–16.
Muenter MD , Forno LS , Hornykiewicz O , et al. Hereditary form of parkinsonism-dementia. Ann Neurol 1998; 43(6): 768–81.
Muller J , Wenning GK , Verny M , et al. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol 2001; 58(2): 259–64.
Muller J , Wenning GK , Wissel J , et al. Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia. J Neurol 2002; 249: 300–4.
Muller V , Mohr B , Rosin R , et al. Short-term effects of behavioral treatment on movement initiation and postural control in Parkinson's disease: a controlled clinical study. Mov Disord 1997; 12(3): 306–14.
Munhoz RP , Teive HA , Troiano AR , et al. Parkinson's disease and thyroid dysfunction. Parkinsonism Relat Disord 2004; 10(6): 381–3.
Munneke M , Keus S , Nijkrake M , et al. Efficiency of evidence-based physiotherapy for Parkinson's disease: the ParkinsonNet trail. Mov Disord 2008; 23(Suppl 1): S220.
Murakami T , Nakajima M , Nakamura T , et al. Parkinsonian symptoms as an initial manifestation in a Japanese patient with acquired immunodeficiency syndrome and Toxoplasma infection. Intern Med 2000; 39(12): 1111–14.
Muraoka T , Oku E , Sugataka K , et al. A case of severe parkinsonism associated with short-term treatment with milnacipran. Clin Neuropharmacol 2008; 31(5): 299–300.
Murgod UA , Muthane UB , Ravi V , et al. Persistent movement disorders following Japanese encephalitis. Neurology 2001; 57(12): 2313–15.
Murray R , Neumann M , Forman MS , et al. Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology 2007; 68: 1274–83.
Nagaoka K , Ookawa S , Maeda K. A case of corticobasal degeneration presenting with visual hallucination. Rinsho Shinkeigaku 2004; 44: 193–7.
Nagasawa H , Tanji H , Nomura H , et al. PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration. J Neurol Sci 1996; 139: 210–7.
Nagatomo S , Umehara F , Hanada K , et al. Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature. J Neurol Sci 1999; 162(1): 102–5.
Nath U , Ben-Shlomo Y , Thomson RG , et al. Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology 2003; 60(6): 892–3.
Nee LE , Gomez MR , Dambrosia J , et al. Environmental-occupational risk factors and familial associations in multiple system atrophy: a preliminary investigation. Clin Auton Res 1991; 1: 9–13.
Neef D , Walling AD. Dementia with Lewy bodies vs Alzheimer's disease. Tips from other journals. Am Fam Physician 2006; 73: 1223–9.
Nicoletti G , Lodi R , Condino F , et al. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain 2006; 129(10): 2679–87.
Nieuwboer A , De WW, Dom R , et al. The effect of a home physiotherapy program for persons with Parkinson's disease. J Rehabil Med 2001; 33(6): 266–72.
Nieuwboer A , Giladi N. The challenge of evaluating freezing of gait in patients with Parkinson's disease. Br J Neurosurg 2008; 22(Suppl 1): S16–18.
Nieuwboer A , Kwakkel G , Rochester L , et al. Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial. J Neurol Neurosurg Psychiatry 2007; 78(2): 134–40.
Nijkrake MJ , Keus SH , Oostendorp RA , et al. Allied health care in Parkinson's disease: referral, consultation, and professional expertise. Mov Disord 2009; 24(2): 282–6.
Nijkrake MJ , Keus SHJ , Kalf JG , et al. Allied health care interventions and complementary therapies in Parkinson's disease. Parkinsonism Rel Disord 2007; 13(Suppl 3): S488–94.
Nijssen PC , Brusse E, Leyten AC , et al. Autosomal dominant adult neuronal ceroid lipofuscinosis: parkinsonism due to both striatal and nigral dysfunction. Mov Disord 2002; 17(3): 482–7.
Nirenberg MJ , Libien J , Vonsattel JP , et al. Multiple system atrophy in a patient with the spinocerebellar ataxia 3 gene mutation. Mov Disord 2007; 22: 251–4.
Nishie M , Mori F , Yoshimoto M , et al. A quantitative investigation of neuronal cytoplasmic and intranuclear inclusions in the pontine and inferior olivary nuclei in multiple system atrophy. Neuropathol Appl Neurobiol 2004; 30: 546–54.
Nishimura M , Kawakami H , Komure O , et al. Contribution of the interleukin-1beta gene polymorphism in multiple system atrophy. Mov Disord 2002; 17: 808–11.
Nishimura M , Kuno S , Kaji R , et al. Influence of a tumor necrosis factor gene polymorphism in Japanese patients with multiple system atrophy. Neurosci Lett 2005; 374: 218–21.
Noble W , Planel E , Zehr C , et al. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci USA 2005; 102: 6990–5.
Noe E , Marder K , Bell KL , et al. Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Mov Disord 2004; 19: 60–7.
Noguchi M , Yoshita M , Matsumoto Y , et al. Decreased beta-amyloid peptide 42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration. J Neurol Sci 2005; 237: 61–5.
Nogueira RG , Baccin CE , Rabinov JD , et al. Reversible parkinsonism after treatment of dural arteriovenous fistula. J Neuroimaging 2009; 19(2): 183–4.
Nonaka M , Imai T , Shintani T , et al. Non-invasive positive pressure ventilation for laryngeal contraction disorder during sleep in multiple system atrophy. J Neurol Sci 2006; 247: 53–8.
Noone ML , Kumar VG , Ummer K , et al. Cirrhosis presenting as Parkinsonism. Ann Indian Acad Neurol 2008; 11(3): 179–81.
O'Brien JT , Erkinjuntti T , Reisberg B , et al. Vascular cognitive impairment. Lancet Neurol 2003; 2 : 89–98.
O'Brien JT , McKeith IG , Walker Z , et al. Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies. Br J Psychiatry 2009; 194: 34–9.
O'Riordan S , McGuigan C , Farrell M , et al. Progressive multifocal leucoencephalopathy presenting with Parkinsonism. J Neurol 2003; 250(11): 1379–81.
O'Sullivan SS , Massey LA , Williams DR , et al. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 2008; 131(5): 1362–72.
O'Sullivan SS , Massey LA , Williams DR , et al. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 2008; 131(5): 1362–72.
Oba H , Yagishita A , Terada H , et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 2005; 64: 2050–5.
Obi K , Akiyama H , Kondo K , et al. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies. Exp Neurol 2008; 210: 409–20.
Oertel WH , Wachter T , Quinn NP , et al. Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type. Mov Disord 2003;18: 430–2.
Ohta K , Obara K. Hemiparkinsonism with a discrete lacunar infarction in the contralateral substantia nigra. Mov Disord 2006; 21(1): 124–5.
Ohtake H , Limprasert P , Fan Y , et al. Beta-synuclein gene alterations in dementia with Lewy bodies. Neurology 2004; 63: 805–11.
Okazaki H , Lipkin L , Aronson S. Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis. J Neuropathol Exp Neurol 1961; 20: 237–44.
Okazaki H , Lipkin LE , Aronson SM. Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 1961; 20: 237–44.
Okuda B , Kawabata K , Tachibana H , et al. Primitive reflexes distinguish vascular parkinsonism from Parkinson's disease. Clin Neurol Neurosurg 2008; 110(6): 562–5.
Okuda B , Kodama N , Tachibana H , et al. Visuomotor ataxia in corticobasal degeneration. Mov Disord 2000; 15: 337–40.
Okun MS , Tagliati M , Pourfar M , et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol 2005; 62: 1250–5.
Olanow CW. Magnetic resonance imaging in parkinsonism. Neurol Clin 1992; 10: 405–20.
Olanow CW. Manganese-induced parkinsonism and Parkinson's disease. Ann NY Acad Sci 2004; 1012: 209–23.
Olive JM , Masana L, Gonzalez J. Meperidine and reversible parkinsonism. Mov Disord 1994; 9(1): 115–6.
Oliveira RM , Gurd JM , Nixon P , et al. Micrographia in Parkinson's disease: the effect of providing external cues. J Neurol Neurosurg Psychiatry 1997; 63(4): 429–33.
Orimo S , Kanazawa T , Nakamura A , et al. Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy. Acta Neuropathol 2007; 113: 81–6.
Orimo S , Ozawa E , Nakade S , et al. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 67: 189–94.
Orta Daniel SJ , Ulises RO . Stroke of the substance nigra and parkinsonism as first manifestation of systemic lupus erythematosus. Parkinsonism Relat Disord 2008; 14(4): 367–9.
Osaki Y , Ben Shlomo Y , Lees AJ , et al. Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord 2004; 19: 181–9.
Osaki Y , Ben Shlomo Y , Less AJ , et al. Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord 2004; 19: 181–9.
Osaki Y , Ben-Shlomo Y , Lees AJ , et al. A validation exercise on the new consensus criteria for multiple system atrophy. Mov Disord 2009; 24(15):2272–6.
Osaki Y , Ben-Shlomo Y , Lees AJ , et al. Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord 2004; 19: 181–9.
Ozawa T , Paviour D , Quinn NP , et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004; 127: 2657–71.
Ozawa T , Takano H , Onodera O , et al. No mutation in the entire coding region of the alpha-synuclein gene in pathologically confirmed cases of multiple system atrophy. Neurosci Lett 1999; 270: 110–12.
Ozawa T. Morphological substrate of autonomic failure and neurohormonal dysfunction in multiple system atrophy: impact on determining phenotype spectrum. Acta Neuropathol 2007; 114: 201–11.
Ozawa T. Pathology and genetics of multiple system atrophy: an approach to determining genetic susceptibility spectrum. Acta Neuropathol (Berl) 2006; 112: 531–8.
Ozsancak C , Auzou P , Dujardin K , et al. Orofacial apraxia in corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy and Parkinson's disease. J Neurol 2004; 251(11): 1317–23.
Ozsancak C , Auzou P , Hannequin D. Dysarthria and orofacial apraxia in corticobasal degeneration. Mov Disord 2000; 15(5): 905–10.
Padilla Parrado F , Campos Arillo VM, Martinez del Valle Torres MD, et al. [Hemiparkinsonism secondary to mesencephalic bleeding]. Neurologia 2007; 22(7): 480–3.
Padrell MD , Navarro M , Faura CC , et al. Verapamil-induced parkinsonism. Am J Med 1995; 99(4): 436.
Paisan-Ruiz C , Jain S , Evans EW , et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004; 44: 595–600.
Palace J , Chandiramani VA , Fowler CJ. Value of sphincter electromyography in the diagnosis of multiple system atrophy. Muscle Nerve 1997; 20: 1396–403.
Pankratz N , Nichols WC , Uniacke SK , et al. Significant linkage of Parkinson disease to chromosome 2q36–37. Am J Hum Genet 2003; 72: 1053–7.
Papapetropoulos S , Argyriou AA , Liossis SN , et al. A case of L-dopa-responsive parkinsonian syndrome after low-dose oral methotrexate intake. Clin Neuropharmacol 2004; 27(2): 95–8.
Papapetropoulos S , Singer C , McCorquodale D , et al. Cause, seasonality of death and co-morbidities in progressive supranuclear palsy (PSP). Parkinsonism Relat Disord 2005; 11(7): 459–63.
Papp MI , Kahn JE , Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy–Drager syndrome). J Neurol Sci 1989; 94(1–3): 79–100.
Papp MI , Kahn JE , Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989; 94(1–3): 79–100.
Papp MI , Lantos PL . The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994; 117 (2): 235–43.
Papp MI , Lantos PL. Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci 1992; 107: 172–82.
Pardini M , Huey ED , Cavanagh AL , et al. Olfactory function in corticobasal syndrome and frontotemporal dementia. Arch Neurol 2009; 66: 92–6.
Parmar RC , Valvi CV , Kamat JR , et al. Chloroquine induced parkinsonism. J Postgrad Med 2000; 46(1): 29–30.
Pastor P , Pastor E , Carnero C , et al. Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene. Ann Neurol 2001; 49: 263–7.
Paviour DC , Price SL , Jahanshahi M , et al. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 2006; 129(4): 1040–9.
Paviour DC , Price SL , Jahanshahi M , et al. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. Mov Disord 2006; 21(7): 989–96.
Paviour DC , Thornton JS , Lees AJ , et al. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy. Mov Disord 2007; 22(1): 68–74.
Pavletic ZS , Bishop MR , Markopoulou K , et al. Drug-induced parkinsonism after allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 17(6): 1185–7.
Pedroso JL , Godeiro-Junior C , Felicio AC , et al. Multi-lacunar strokes mimicking atypical parkinsonism with an unusual neuroimaging presentation: état criblé. Arq Neuropsiquiatr 2008; 66(4): 906–7.
Pellecchia MT , Longo K , Pivonello R , et al. Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test. Ann Neurol 2006; 60(5): 611–15.
Pellecchia MT , Pivonello R , Colao A , et al. Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease. Clin Med Res 2006; 4(4): 322–5.
Peralta C , Stamfer M , Karner E , et al. Orthostatic hypotension and attention in Lewy body disorders. Mov Disord 2004; 19: S331–2.
Peralta C , Werner P , Holl B , et al. Parkinsonism following striatal infarcts: incidence in a prospective stroke unit cohort. J Neural Transm 2004; 111(10–11): 1473–83.
Perani D , Bressi S , Testa D , et al. Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study. Arch Neurol 1995; 52(2): 179–85.
Perera R , Isola L , Kaufmann H. Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure. Clin Auton Res 1995; 5: 211–13.
Perez Lloret S , Amaya M , Merello M . Pregabalin-induced parkinsonism: a case report. Clin Neuropharmacol 2009; 32(6): 353–4.
Perlman AL , Schulze-Delrieu KS. Deglutition and its Disorders. San Diego: Singular Publishing Group, 1997.
Petzold A , Thompson EJ , Keir G , et al. Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy. J Neurol Sci 2009; 279: 76–9.
Pfeiffer RF. Wilson's Disease. Semin Neurol 2007; 27(2): 123–32.
Pharr V , Uttl B , Stark M , et al. Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy. Neurology 2001; 56(7): 957–63.
Pharr V , Uttl B , Stark M , et al. Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy. Neurology 2001; 56: 957–63.
Piao YS , Mori F , Hayashi S , et al. α-Synuclein pathology affecting Bergmann glia of the cerebellum in patients with α-synucleinopathies. Acta Neuropathol 2003; 105: 403–9.
Pillon B , Blin J , Vidailhet M , et al. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology 1995; 45: 1477–83.
Pinarbasi B , Kaymakoglu S , Matur Z , et al. Are acquired hepatocerebral degeneration and hepatic myelopathy reversible? J Clin Gastroenterol 2009; 43(2): 176–81.
Plato CC , Garruto RM , Galasko D , et al. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol 2003; 157(2): 149–57.
Plesner AM , Arlien-Soborg P , Herning M. Neurological complications to vaccination against Japanese encephalitis. Eur J Neurol 1998; 5(5): 479–85.
Pletnikova O , West N , Lee MK , et al. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol Aging 2005; 26: 1183–92.
Poewe W , Wolters E , Emre M , et al. Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study. Mov Disord 2006; 21(4): 456–61.
Poewe W. Dysautonomia and cognitive dysfunction in Parkinson's disease. Mov Disord 2005; (Suppl 17): 374–78.
Poewe WH , Wenning GK. The natural history of PD. Ann Neurol 1998; 44: S1–9.
Pohle T , Krauss JK . Parkinsonism in children resulting from mesencephalic tumors. Mov Disord 1999; 14(5): 842–6.
Pollock NJ , Mirra SS , Binder LI , et al. Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease share antigenic determinants with microtubule- associated protein, tau. Lancet; 2(8517): 1211.
Pollock NJ , Mirra SS , Binder LI , et al. Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease share antigenic determinants with microtubule-associated protein, tau. Lancet 1986; 2(8517): 1211.
Portala K , Westermark K , Ekselius L , et al. Sleep in patients with treated Wilson's disease. A questionnaire study. Nord J Psychiatry 2002; 56: 291–7.
Portera-Cailliau C , Russ C , Brown RH Jr, et al. A familial form of pallidoluysionigral degeneration and amyotrophic lateral sclerosis with divergent clinical presentations. J Neuropathol Exp Neurol 2007; 66(7): 650–9.
Poser CM , Huntley CJ , Poland JD . Para-encephalitic parkinsonism. Report of an acute case due to coxsackie virus type B2 and re-examination of the etiologic concepts of postencephalitic parkinsonism. Acta Neurol Scand 1969; 45(2): 199–215.
Pranzatelli MR , Mott SH , Pavlakis SG , et al. Clinical spectrum of secondary parkinsonism in childhood: a reversible disorder. Pediatr Neurol 1994; 10(2): 131–40.
Prashantha DK , Netravathi M , Ravishankar S , et al. Reversible parkinsonism following ventriculoperitoneal shunt in a patient with obstructive hydrocephalus secondary to intraventricular neurocysticercosis. Clin Neurol Neurosurg 2008; 110(7): 718–21.
Probst-Cousin S , Rickert CH , Schmid KW , et al. Cell death mechanisms in multiple system atrophy. J Neuropathol Exp Neurol 1998; 57: 814–21.
Prodan CI , Monnot M , Ross ED , et al. Reversible dementia with parkinsonian features associated with budesonide use. Neurology 2006; 67(4): 723.
Provini F , Vetrugno R , Pierangeli G , et al. Sleep and temperature rhythms in two sisters with P102L Gerstmann-Straussler-Scheinker (GSS) disease. Sleep Med 2009; 10(3): 374–7.
Purisai MG , McCormack AL , Langston WJ , et al. Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates. Neurobiol Dis 2005; 20: 898–906.
Quattrone A , Nicoletti G , Messina D , et al. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 2008; 246: 214–21.
Quattrone A , Nicoletti M , Messina D , et al. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 2008; 246: 214–21.
Quinn N , Koller WC , Lang AE , et al. Painful Parkinson's disease. Lancet 1996; 1: 1366–9.
Quinn N. Multiple system atrophy – the nature of the beast. J Neurol Neurosurg Psychiatry Suppl 1989; 78–89.
Quinn N. Multiple system atrophy the nature of the beast. J Neurol Neurosurg Psychiatry 1989; Suppl: 78–89.
Quinn N. Parkinsonism – recognition and differential diagnosis. BMJ 1995; 310(6977): 447–52.
Quinn NP. How to diagnose multiple system atrophy. Mov Disord 2005; 20: S5–10.
Rademakers R , Melquist S , Cruts M , et al. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum Mol Genet 2005; 14: 3281–92.
Rahkonen T , Eloniemi-Sulkava U , Rissanen S , et al. Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J Neurol Neurosurg Psychiatry 2003; 74: 720–4.
Raimbach SJ , Cortelli P , Kooner JS , et al. Prevention of glucose-induced hypotension by the somatostatin analogue octreotide (SMS 201–995) in chronic autonomic failure: haemodynamic and hormonal changes. Clin Sci (Lond) 1989; 77: 623–8.
Raison CL , Demetrashvili M , Capuron L , et al. Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs 2005; 19(2): 105–23.
Ramig LO , Countryman S , O'Brien C , et al. Intensive speech treatment for patients with Parkinson's disease: short- and long-term comparison of two techniques. Neurology 1996; 47(6): 1496–504.
Ramig LO , Countryman S , Thompson LL , et al. Comparison of two forms of intensive speech treatment for Parkinson disease. J Speech Hear Res 1995; 38(6): 1232–51.
Ravina B , Putt M , Siderowf A , et al. Donepezil for dementia in Parkinson's disease: a randomized, double blind, placebo-controlled, crossover study. J Neurol Neurosurg Psychiatry 2005; 76(7): 934–9.
Rebeiz JJ , Kolodny EH , Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968; 18(1): 20–33.
Rebeiz JJ , Kolodny EH , Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968; 18: 20–33.
Reddy NJ , Lewis LD , Gardner TB , et al. Two cases of rapid onset Parkinson's syndrome following toxic ingestion of ethylene glycol and methanol. Clin Pharmacol Ther 2007; 81(1): 114–21.
Reijneveld JC , Taphoorn MJ , Hoogenraad TU , et al. Severe but transient parkinsonism after tetanus vaccination. J Neurol Neurosurg Psychiatry 1997; 63(2): 258.
Rektor I , Rektorova I , Kubova D. Vascular parkinsonism – an update. J Neurol Sci 2006; 248: 185–91.
Remblier C , Kassir A , Richard D , et al. [Parkinson syndrome from diltiazem]. Therapie 2001; 56(1): 57–9.
Reuter I , Hu MT , Andrews TC , et al. Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome. J Neurol Neurosurg Psychiatry 2000; 68(2): 238–41.
Richard IH , Papka M , Rubio A , et al. Parkinson's disease and dementia with Lewy bodies: one disease or two? Mov Disord 2002; 17: 1161–5.
Richardson JC , Steele JC , Olszewski J. Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. Trans Am Neurol Assoc 1963; 8: 25–9.
Riley DE , Fogt N , Leigh RJ. The syndrome of ‘pure akinesia’ and its relationship to progressive supranuclear palsy. Neurology 1994; 44: 1025–9.
Riley DE , Lang AE , Lewis A , et al. Cortical-basal ganglionic degeneration. Neurology 1990; 40(8): 1203–12.
Riley DE , Lang AE , Lewis A , et al. Cortical-basal ganglionic degeneration. Neurology 1990; 40: 1203–12.
Rinne JO , Lee MS , Thompson PD , et al. Corticobasal degeneration. A clinical study of 36 cases. Brain 1994; 117: 1183–96.
Rivaud-Pechoux S , Vidailhet M , Gallouedec G , et al. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology 2000; 54: 1029–32.
Rochon PA , Stukel TA , Sykora K , et al. Atypical antipsychotics and parkinsonism. Arch Intern Med 2005; 165(16): 1882–8.
Romano S , Colosimo C. Procerus sign in progressive supranuclear palsy. Neurology 2001; 57: 1928.
Romano S , Colosimo C. Procerus sign in progressive supranuclear palsy. Neurology 2001; 57: 1928.
Rondot P , Bathien N , de Recondo J , et al. Dystonia-parkinsonism syndrome resulting from a bullet injury in the midbrain. J Neurol Neurosurg Psychiatry 1994; 57(5): 658.
Ros R , Gomez GP , Hirano M , et al. Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1. Ann Neurol 2005; 57: 634–41.
Roselli F , Russo I , Fraddosio A , et al. Reversible Parkinsonian syndrome associated with anti-neuronal antibodies in acute EBV encephalitis: a case report. Parkinsonism Relat Disord 2006; 12(4): 257–60.
Ross OA , Toft M , Whittle AJ , et al. Lrrk2 and Lewy body disease. Ann Neurol 2006; 59: 388–93.
Ross RT. Drug-induced parkinsonism and other movement disorders. Can J Neurol Sci 1990; 17(2): 155–62.
Rossi G , Marelli C , Farina L , et al. The G389R mutation in the MAPT gene presenting as sporadic corticobasal syndrome. Mov Disord 2008; 23: 892–5.
Roze E , Cochen V , Sangla S , et al. Rett syndrome: an overlooked diagnosis in women with stereotypic hand movements, psychomotor retardation, Parkinsonism, and dystonia? Mov Disord 2007; 22(3): 387–9.
Roze E , Paschke E , Lopez N , et al. Dystonia and parkinsonism in GM1 type 3 gangliosidosis. Mov Disord 2005; 20(10): 1366–9.
Rudnicki SA , Harik SI , Dhodapkar M , et al. Nervous system dysfunction in Waldenstrom's macroglobulinemia: response to treatment. Neurology 1998; 51(4): 1210–13.
Sa DS , Galvez-Jimenez N , Lang AE . Psychogenic movement disorders. In: Movement Disorders: Neurologic Principles & Practice. Watts RL , Koller WC , eds. New York: McGraw-Hill, 2004; 891–914.
Sa DS , Teive HA , Troiano AR , et al. Parkinsonism associated with neurocysticercosis. Parkinsonism Relat Disord 2005; 11(1): 69–72.
Sachin S , Shukla G , Goyal V , et al. Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy. Neurol India 2008; 56(2): 122–6.
Sadeh M , Goldhammer Y . Extrapyramidal syndrome responsive to dopaminergic treatment following recovery from central pontine myelinolysis. Eur Neurol 1993; 33(1): 48–50.
Saidha S , Mok TH , Butler M, et al. Multiple sclerosis exceptionally presenting as parkinsonism responds to intravenous methylprednisolone. J Clin Neurosci 2010; 17(5): 654–5.
Sakakibara R , Hattori T , Uchiyama T , et al. Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte. J Auton Nerv Syst 2000; 79: 191–5.
Sakakibara R , Hattori T , Uchiyama T , et al. Urinary dysfunction and orthostatic hypotension in multiple system atrophy: which is the more common and earlier manifestation? J Neurol Neurosurg Psychiatry 2000; 68(1): 65–9.
Sakakibara R , Hattori T , Uchiyama T , et al. Videourodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 2001; 71: 600–6.
Sakakibara R , Shinotoh H , Uchiyama T , et al. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. Auton Neurosci 2001; 92: 76–85.
Sakakibara R , Uchiyama T , Yamanishi T , et al. Sphincter EMG as a diagnostic tool in autonomic disorders. Clin Auton Res 2009; 19: 20–31.
Sakurai A , Okamoto K , Yaguchi M , et al. Pathology of the inferior olivary nucleus in patients with multiple system atrophy. Acta Neuropathol (Berl) 2002; 103: 550–4.
Sanchez-Guerra M , Cerezal L , Leno C , et al. Primary brain lymphoma presenting as Parkinson's disease. Neuroradiology 2001; 43(1): 36–40.
Sandyk R. Parkinsonism induced by captopril. Clin Neuropharmacol 1985; 8(2): 197–8.
Sandyk R. Parkinsonism induced by diazepam. Biol Psychiatry 1986; 21(12): 1232–3.
Santens P , Vonck K , De Letter M , et al. Deep brain stimulation of the internal pallidum in multiple system atrophy. Parkinsonism Relat Disord 2006; 12(3): 181–3.
Sato S , Nakamura K , Nakahara T , et al. [Distigmine bromide induced Parkinsonism. A case report]. Rinsho Shinkeigaku 2005; 45(8): 600–2.
Sawaishi Y , Yano T , Watanabe Y , et al. Migratory basal ganglia lesions in subacute sclerosing panencephalitis (SSPE): clinical implications of axonal spread. J Neurol Sci 1999; 168(2): 137–40.
Sawle GV , Brooks DJ , Marsden CD , et al. Corticobasal degeneration. A unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain 1991; 114: 541–56.
Scandalis TA , Bosak A , Berliner JC , et al. Resistance training and gait function in patients with Parkinson's disease. Am J Phys Med Rehabil 2001; 80(1): 38–43.
Scepkowski LA , Cronin-Golomb A. The alien hand: cases, categorizations, and anatomical correlates. Behav Cogn Neurosci Rev 2003; 2: 261–77.
Schabitz WR , Glatz K , Schuhan C , et al. Severe forward flexion of the trunk in Parkinson's disease: focal myopathy of the paraspinal muscles mimicking camptocormia. Mov Disord 2003; 18: 408–14.
Schenkman M , Cutson TM , Kuchibhatla M , et al. Exercise to improve spinal flexibility and function for people with Parkinson's disease: a randomized, controlled trial. J Am Geriatr Soc 1998; 46(10): 1207–16.
Scherfler C , Puschban Z , Ghorayeb I , et al. Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy). Neuroscience 2000; 99: 43–54.
Scherfler C , Seppi K , Donnemiller E , et al. Voxel-wise analysis of [123I] beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease. Brain 2005; 128: 1605–12.
Schmeichel AM , Buchhalter LC , Low PA , et al. Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy. Neurology 2008; 70: 368–73.
Schneider JA , Watts RL , Gearing M , et al. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology 1997; 48: 959–69.
Schocke MF , Seppi K , Esterhammer R , et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 2002; 58: 575–80.
Scholz SW , Houlden H , Schulte C , et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 2009; 65(5): 610–14.
Scholz SW , Houlden H , Schulte C , et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 2009; 65(5): 610–14.
Scholz SW , Houlden H , Sculte C , et al. SNCA variants are associated with increased risk of multiple system atrophy. Ann Neurol 2009; 65(5): 610–14.
Schrag A , Ben-Shlomo Y , Quinn NP . Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 1999; 354: 1771–5.
Schrag A , Ben-Shlomo Y , Quinn NP. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 1999; 354: 1771–5.
Schrag A , Geser F , Stampfer-Kountchev M , et al. Health-related quality of life in multiple system atrophy. Mov Disord 2006; 21: 809–15.
Schrag A , Good CD , Miszkiel K , et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000; 54: 697–702.
Schrag A , Good CD , Miszkiel K , et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000; 54: 697–702.
Schrag A , Wenning GK , Quinn N , et al. Survival in multiple system atrophy. Mov Disord 2008; 23(2): 294–6.
Schultz DR , Barthal JS , Garrett G . Western equine encephalitis with rapid onset of parkinsonism. Neurology 1977; 27(11): 1095–6.
Schulz JB , Skalej M , Wedekind D , et al. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1999; 45: 65–74.
Schwarz J , Tatsch K , Arnold G , et al. 123I-iodobenzamide-SPECT in 83 patients with de novo parkinsonism. Neurology 1993; 43: 17–20.
Schwarz J , Tatsch K , Gasser T , et al. 123I-IBZM binding compared with long-term clinical follow-up in patients with de novo parkinsonism. Mov Disord 1998; 13: 16–19.
Schwarz J , Weis S , Kraft E , et al. Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy. J Neurol Neurosurg Psychiatry 1996; 60: 98–101.
Sechi GP , Agnetti V , Piredda M , et al. Acute and persistent parkinsonism after use of diquat. Neurology 1992; 42(1): 261–3.
Sedel F , Ribeiro MJ , Remy P , et al. Dihydropteridine reductase deficiency: levodopa's long-term effectiveness without dyskinesia. Neurology 2006; 67(12): 2243–5.
Sedel F , Saudubray JM , Roze E, et al. Movement disorders and inborn errors of metabolism in adults: a diagnostic approach. J Inherit Metab Dis 2008; 31(3): 308–18.
Sejvar JJ , Haddad MB , Tierney BC , et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003; 290(4): 511–15.
Seo JH , Song SK , Lee PH . A novel PANK2 mutation in a patient with atypical pantothenate-kinase-associated neurodegeneration presenting with adult-onset parkinsonism. J Clin Neurol 2009; 5(4): 192–4.
Seppi K , Peralta C , Diem-Zangerl A , et al. Placebo-controlled trial of riluzole in multiple system atrophy. Eur J Neurol 2006; 13(10): 1146–8.
Seppi K , Schocke MF , Esterhammer R , et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the Parkinson variant of multiple system atrophy. Neurology 2003; 60(6): 922–7.
Seppi K , Schocke MFH , Esterhammer R , et al. DWI discriminates PSP from PD, but not from the Parkinson variant of multiple system atrophy, Neurology 2003; 60: 922–7.
Seppi K , Wenning GK , Jellinger K , et al. Disease progression of dementia with Lewy bodies: a clinicopathological study. Neurology 2000; 54(Suppl 3): S64.002
Serrano-Duenas M. [Parkinsonism or Parkinson's disease unmasked by pentoxifylline?] Neurologia 2001; 16(1): 39–42.
Shahar E , Bentur Y , Bar-Joseph G , et al. Extrapyramidal parkinsonism complicating acute organophosphate insecticide poisoning. Pediatr Neurol 2005; 33(5): 378–82.
Shahar E , Keidan I , Brand N , et al. Uncommon neurologic complications of burns in infants: a parkinsonian extrapyramidal disorder and massive cerebral infarction. J Burn Care Rehabil 1991; 12(1): 54–7.
Shannon JR , Diedrich A , Biaggioni I , et al. Water drinking as a treatment for orthostatic syndromes. Am J Med 2002; 112(5): 355–60.
Shiba M , Bower JH , Maraganore DM , et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord 2000; 15: 669–77.
Shin HW , Kim MJ , Kim JS , et al. Levosulpiride-induced movement disorders. Mov Disord 2009; 24(15): 2249–53.
Shin HW , Song D , Sohn YH . Normal diffusion-weighted MR imaging predicts a good prognosis in extrapontine myelinolysis-induced parkinsonism. Mov Disord 2009; 24(11): 1701–3.
Shintaku M , Oyanagi K , Kaneda D . Amyotrophic lateral sclerosis with dementia showing clinical parkinsonism and severe degeneration of the substantia nigra: report of an autopsy case. Neuropathology 2007; 27(3): 295–9.
Shults CW , Rockenstein E , Crews L , et al. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. J Neurosci 2005; 25: 10 689–99.
Shy GM , Drager GA. A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study. Arch Neurol 1960; 2: 511–27.
Shy GM , Drager GA. A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study. Arch Neurol 1960; 2: 511–27.
Sibon I , Fenelon G , Quinn NP , et al. Vascular parkinsonism. J Neurol 2004; 251(5): 513–24.
Sibon I , Tison F. Vascular parkinsonism. Curr Opin Neurol 2004; 17: 49–54.
Siderowf AD , Galetta SL , Hurtig HI , et al. Posey and Spiller and progressive supranuclear palsy: an incorrect attribution. Mov Disord 1998; 13: 170–4.
Sikk K , Taba P , Haldre S , et al. Clinical, neuroimaging and neurophysiological features in addicts with manganese-ephedrone exposure. Acta Neurol Scand 2010; 121(4): 237–43.
Sikk K , Taba P , Haldre S , et al. Irreversible motor impairment in young addicts – ephedrone, manganism or both? Acta Neurol Scand 2007; 115(6): 385–9.
Silvers DS , Menkes DL . Hemibody mirror movements in hemiparkinsonism-hemiatrophy syndrome. J Neurol Sci 2009; 287(1–2): 260–3.
Simon DK , Pulst SM , Sutton JP , et al. Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation. Neurology 1999; 53(8): 1787–93.
Simons G , Thompson SB , Smith Pasqualini MC . An innovative education programme for people with Parkinson's disease and their carers. Parkinsonism Relat Disord 2006; 12(8): 478–85.
Singer C , Schatz NJ , Bowen B , et al. Asymmetric predominantly ipsilateral blepharospasm and contralateral parkinsonism in an elderly patient with a right mesencephalic cyst. Mov Disord 1998; 13(1): 135–9.
Singleton AB , Farrer M , Johnson J , et al. α-Synuclein locus triplication causes Parkinson's disease. Science 2003; 302: 841.
Snijders AH , Nijkrake MJ , Bakker M , et al. Clinimetrics of freezing of gait. Mov Disord 2008; 23(Suppl 2): S468–74.
Snijders AH , van de Warrenburg BP , Giladi N , et al. Neurological gait disorders in elderly people: clinical approach and classification. Lancet Neurol 2007; 6(1): 63–74.
Sobel N , Prabhakaran V , Hartley CA , et al. Odorant-induced and sniff-induced activation in the cerebellum of the human. J Neurosci 1998; 18: 8990–9001.
Solano SM , Miller DW , Augood SJ , et al. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease. Ann Neurol 2000; 47: 201–10.
Solano SM , Miller DW , Augood SJ , et al. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease. Ann Neurol 2000; 47: 201–10.
Soliveri P , Piacentini S , Girotti F. Limb apraxia in corticobasal degeneration and progressive supranuclear palsy. Neurology 2005; 64: 448–53.
Soma H , Yabe I , Takei A , et al. Associations between multiple system atrophy and polymorphisms of SLC1A4, SQSTM1, and EIF4EBP1 genes. Mov Disord 2008; 23: 1161–7.
Soma H , Yabe I , Takei A , et al. Heredity in multiple system atrophy. J Neurol Sci 2006; 240: 107–10.
Sone M , Yoshida M , Hashizume Y , et al. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy. Acta Neuropathol (Berl) 2005; 110: 19–26.
Song YJ , Lundvig DM , Huang Y , et al. p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. Am J Pathol 2007; 171: 1291–303.
Spencer PS , Palmer VS , Ludolph AC . On the decline and etiology of high-incidence motor system disease in West Papua (southwest New Guinea). Mov Disord 2005; 20(Suppl 12): S119–26.
Spillantini MG , Crowther RA , Jakes R , et al. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 1998; 251(3): 205–8.
Spillantini MG , Crowther RA , Jakes R , et al. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 1998; 251: 205–8.
Spillantini MG , Schmidt ML , Lee VM , et al. α-Synuclein in Lewy bodies. Nature 1997; 388: 839–40.
Spillantini MG , Yoshida H , Rizzini C , et al. A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies. Ann Neurol 2000; 48: 939–43.
Spina S , Murrell JR , Huey ED , et al. Corticobasal syndrome associated with the A9D Progranulin mutation. J Neuropathol Exp Neurol 2007; 66: 892–900.
Spitz M , Maia FM , Gomes HR , et al. Parkinsonism secondary to neurosyphilis. Mov Disord 2008; 23(13): 1948–9.
Stallibrass C , Sissons P , Chalmers C. Randomized controlled trial of the Alexander technique for idiopathic Parkinson's disease. Clin Rehabil 2002; 16(7): 695–708.
Stamelou M , Reuss A , Pilatus U , et al. Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial. Mov Disord 2008; 23: 942–9.
Steele JC , Richardson JC , Olszewski J. Progressive Supranuclear Palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964; 10: 333–59.
Steele JC , Richardson JC , Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964; 10: 333–59.
Steele JC. Parkinsonism-dementia complex of Guam. Mov Disord 2005; 20(Suppl 12): S99–107.
Stefanova N , Lundblad M , Tison F , et al. Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy). Neurobiol Dis 2004; 15: 630–9.
Stefanova N , Puschban Z , Fernagut PO , et al. Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy). Acta Neuropathol (Berl) 2003; 106: 157–66.
Stefanova N , Reindl M , Neumann M , et al. Microglial activation mediates neurodegeneration related to oligodendroglial alpha-synucleinopathy: implications for multiple system atrophy. Mov Disord 2007; 22(15): 2196–203.
Stefanova N , Reindl M , Neumann M , et al. Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Am J Pathol 2005; 166: 869–76.
Stefanova N , Tison F , Reindl M , et al. Animal models of multiple system atrophy. Trends Neurosci 2005; 28(9): 501–6.
Stefanova N , Tison F , Reindl M , et al. Animal models of multiple system atrophy. Trends Neurosci 2005; 28(9): 501–6.
Steffen TM , Boeve BF , Mollinger-Riemann LA , et al. Long-term locomotor training for gait and balance in a patient with mixed progressive supranuclear palsy and corticobasal degeneration. Phys Ther 2007; 87: 1078–87.
Stepens A , Logina I , Liguts V , et al. A Parkinsonian syndrome in methcathinone users and the role of manganese. N Engl J Med 2008; 358(10): 1009–17.
Stolze H , Kuhtz-Buschbeck JP , Drucke H , et al. Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson's disease. J Neurol Neurosurg Psychiatry 2001; 70(3): 289–97.
Stover NP , Watts RL. Corticobasal degeneration. Semin Neurol 2001; 21: 49–58.
Strang RR. Parkinsonism occurring during methyldopa therapy. Can Med Assoc J 1966; 95(18): 928–9.
Stremmel W , Meyerrose KW , Niederau C , et al. Wilson's disease: clinical presentation, treatment, and survival. Ann Intern Med 1991; 115: 720–6.
Sturkenboom IHWM , Kalf JG , Bloem BR , et al. Guidelines for occupational therapy in Parkinson's disease. Mov Disord 2008; 23: S329.
Sturkenboom IHWM , Thijssen MCE , Gons-van Elsacker JJ , et al. Ergotherapie bij de ziekte van Parkinson. Een richtlijn van Ergotherapie Nederland. Utrecht: Ergotherapie Nederland/Uitgeverij LEMMA, 2008.
Su CS , Chang WN , Huang SH , et al. Cerebrotendinous xanthomatosis patients with and without parkinsonism: clinical characteristics and neuroimaging findings. Mov Disord 2010; 25(4): 452–8.
Sundar PD , Yu CE , Sieh W , et al. Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia. Hum Mol Genet 2007; 16(3): 295–306.
Susatia F , Fernandez HH . Drug-induced parkinsonism. Curr Treat Options Neurol 2009; 11(3): 162–9.
Sutter D , Curdt T , Neufeld P. Promoting community participation among persons with Parkinson's and their caregivers: occupational therapy practitioners can facilitate persons with Parkinson's disease finding ways to continue to participate in valued occupation. OT Practice 2006; 11: 19–22.
Swart de BJ , Willemse SC , Maassen BA , et al. Improvement of voicing in patients with Parkinson's disease by speech therapy. Neurology 2003; 60(3): 498–500.
Tada M , Kakita A , Toyoshima Y , et al. Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death. Brain 2009; 132: 1810–19.
Takahashi H , Yoshida K , Sugita T , et al. Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case series. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 549–53.
Takeda A , Arai N , Komori T , et al. Tau immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 1997; 234: 63–6.
Takeda A , Mallory M , Sundsmo M , et al. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Am J Pathol 1998; 152(2): 367–72.
Taki J , Yoshita M , Tamada M , et al. Significance of I-123-metaiodobenzylguanidine scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related movement disorders: It can be a specific marker for Lewy body disease. Ann Nucl Med 2004; 18: 453–61.
Taly AB , Meenakshi-Sundaram S , Sinha S , et al. Wilson disease: description of 282 patients evaluated over 3 decades. Medicine (Baltimore) 2007; 86(2): 112–21.
Tan EK , Chan LL , Yu GX , et al. Vascular parkinsonism in moyamoya: microvascular biopsy and imaging correlates. Ann Neurol 2003; 54(6): 836–40.
Tan EK , Tong J , Pavanni R , et al. Genetic analysis of SCA 2 and 3 repeat expansions in essential tremor and atypical Parkinsonism. Mov Disord 2007; 22(13): 1971–4.
Tan JH , Goh BC , Tambyah PA , et al. Paraneoplastic progressive supranuclear palsy syndrome in a patient with B-cell lymphoma. Parkinsonism Relat Disord 2005; 11(3): 187–91.
Tang-Wai DF , Josephs KA , Boeve BF , et al. Pathologically confirmed corticobasal degeneration presenting with visuospatial dysfunction. Neurology 2003; 61: 1134–5.
Tashiro K , Ogata K , Goto Y , et al. EEG findings in early-stage corticobasal degeneration and progressive supranuclear palsy: a retrospective study and literature review. Clin Neurophysiol 2006; 117: 2236–42.
Tayebi N , Walker J , Stubblefield B , et al. Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab 2003; 79(2): 104–9.
Teive HA , Germiniani FM , Werneck LC . Parkinsonian syndrome induced by amlodipine: case report. Mov Disord 2002; 17(4): 833–5.
Teive HA , Troiano AR , Germiniani FM , et al. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis. Parkinsonism Relat Disord 2004; 10(4): 243–5.
Thanvi B , Lo N , Robinson T. Vascular parkinsonism – an important cause of parkinsonism in older people. Age Ageing 2005; 34(2): 114–9.
Thanvi B , Treadwell S . Drug induced parkinsonism: a common cause of parkinsonism in older people. Postgrad Med J 2009; 85(1004): 322–6.
Thaut MH , McIntosh GC , Rice RR , et al. Rhythmic auditory stimulation in gait training for Parkinson's disease patients. Mov Disord 1996; 11(2): 193–200.
Thobois S , Broussolle E , Toureille L , et al. Severe dysphagia after botulinum toxin injection for cervical dystonia in multiple system atrophy. Mov Disord 2001; 16: 764–5.
Thompson PD , Day BL , Rothwell JC , et al. The myoclonus in corticobasal degeneration. Evidence for two forms of cortical reflex myoclonus. Brain 1994; 117: 1197–207.
Thornton JE , Stahl SM . Case report of tardive dyskinesia and parkinsonism associated with amoxapine therapy. Am J Psychiatry 1984; 141(5): 704–5.
Thrash B , Uthayathas S , Karuppagounder SS , et al. Paraquat and maneb induced neurotoxicity. Proc West Pharmacol Soc 2007; 50: 31–42.
Thumler BH , Urban PP , Davids E , et al. Dysarthria and pathological laughter/crying as presenting symptoms of corticobasal-ganglionic degeneration syndrome. J Neurol 2003; 250: 1107–8.
Thyagarajan D , Bressman S , Bruno C , et al. A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy. Ann Neurol 2000; 48(5): 730–6.
Tinazzi M , Antonini A , Bovi T , et al. Clinical and [123I]FP-CIT SPET imaging follow-up in patients with drug-induced parkinsonism. J Neurol 2009; 256(6): 910–5.
Tisch S, Brew B. Parkinsonism in HIV-infected patients on highly active antiretroviral therapy. Neurology 2009; 73(5): 401–3.
Tissingh G , Berendse HW , Bergmans P , et al. Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Mov Disord 2001; 16: 41–6.
Togasaki DM , Tanner CM. Epidemiologic aspects. Adv Neurol 2000; 82: 53–9.
Tolosa E , Coelho M , Gallardo M . DAT imaging in drug-induced and psychogenic parkinsonism. Mov Disord 2003; 18(Suppl 7): S28–33.
Tolosa E , Valldeoriola F , Marti MJ . Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). J Neural Transm Suppl 1994; 42: 15–31.
Toole T , Hirsch MA , Forkink A , et al. The effects of a balance and strength training program on equilibrium in Parkinsonism: A preliminary study. NeuroRehabilitation 2000; 14(3): 165–74.
Toovey S. Influenza-associated central nervous system dysfunction: a literature review. Travel Med Infect Dis 2008; 6(3): 114–24.
Trender-Gerhard I , Sweeney MG , Schwingenschuh P, et al. Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J Neurol Neurosurg Psychiatry 2009; 80(8): 839–45.
Trojanowski JQ , Revesz T. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol 2007; 33(6): 615–20.
Trompetto C , Buccolieri A , Marchese R , et al. Impairment of transcallosal inhibition in patients with corticobasal degeneration. Clin Neurophysiol 2003; 114: 2181–7.
Tsuang DW , Di Giacomo L, Bird TD. Familial occurrence of dementia with Lewy bodies. Am J Geriatr Psychiatry 2004; 12: 179–88.
Tsuboi Y , Dickson DW . Dementia with Lewy bodies and Parkinson's disease with dementia: are they different? Parkinsonism Relat Disord 2005; 11(Suppl 1): S47–51.
Tsuboi, Y. [Clinical, pathological, and genetic characteristics of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in the MAPT and PGRN]. Brain Nerve 2009; 61(11): 1285–91.
Tsuji S , Onodera O , Goto J , et al. Sporadic ataxias in Japan – a population-based epidemiological study. Cerebellum 2008; 7(2): 189–97.
Tu PH , Galvin JE , Baba M , et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol 1998; 44: 415–22.
Tuite PJ , Clark HB , Bergeron C , et al. Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy. Arch Neurol 2005; 62: 1453–7.
Tuite PJ , Krawczewski K. Parkinsonism: A review-of-systems approach to diagnosis. Semin Neurol 2007; 27: 113–22.
Tumilasci OR , Cersosimo MG , Belforte JE , et al. Quantitative study of salivary secretion in Parkinson's disease. Mov Disord 2006; 21(5): 660–7.
Tunnell E , Wollman R , Mallik S , et al. A novel PRNP-P105S mutation associated with atypical prion disease and a rare PrPSc conformation. Neurology 2008; 71(18): 1431–8.
Uchihara T , Nakayama H. Familial tauopathy mimicking corticobasal degeneration an autopsy study on three siblings. J Neurol Sci 2006; 246: 45–51.
Uchikado H , Tsuchiya K , Tominaga I , et al. [Argyrophilic grain disease clinically mimicking Parkinson's disease with dementia: report of an autopsy case]. No To Shinkei 2004; 56(9): 785–8.
Uitti RJ , Snow BJ , Shinotoh H, et al. Parkinsonism induced by solvent abuse. Ann Neurol 1994; 35(5): 616–19.
Ukmar M , Moretti R , Torre P , et al. Corticobasal degeneration: structural and functional MRI and single-photon emission computed tomography. Neuroradiology 2003; 45: 708–12.
Uldry PA , Bogousslavsky J . Partially reversible parkinsonism in Whipple's disease with antibiotherapy. Eur Neurol 1992; 32(3): 151–3.
Uldry PA , Bogousslavsky J, Petridis A, et al. Aneurysm presenting as parkinsonism. Neurology 2006; 67(11): 2028.
Urakami K , Mori M , Wada K , et al. A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy. Neurosci Lett 1999; 259: 127–9.
Urakami K , Mori M , Wada K , et al. A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy. Neurosci Lett 1999; 259: 127–9.
Urakami K , Wada K , Arai H , et al. Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy. J Neurol Sci 2001; 183: 95–8.
Uryu K , Nakashima-Yasuda H , Forman MS , et al. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 2008; 67: 555–64.
Valldeoriola F , Nobbe FA , Tolosa E . Treatment of behavioural disturbances in Parkinson's disease. J Neural Transm 1997; Suppl 51: 175–204.
Valldeoriola F , Valls-Sole J , Tolosa ES , et al. Striated anal sphincter denervation in patients with progressive supranuclear palsy. Mov Disord 1995; 10: 550–5.
Valls-Solé J. Neurophysiological aids to the diagnosis of progressive supranuclear palsy (PSP). Suppl Clin Neurophysiol 2006; 58: 249–56.
Van Gerpen JA. Drug-induced parkinsonism. Neurologist 2002; 8(6): 363–70.
van Heugten CM , Dekker J , Deelman BG , et al. Outcome of strategy training in stroke patients with apraxia: a phase II study. Clin Rehabil 1998; 12(4): 294–303.
van Royen E , Verhoeff NF , Speelman JD , et al. Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography. Arch Neurol 1993; 50: 513–16.
van Zagten M , Lodder J , Kessels F. Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions. Mov Disord 1998; 13: 89–95.
Vanacore N , Bonifati V , Fabbrini G , et al. Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms. Neurology 2000; 54: 114–19.
Vanacore N , Bonifati V , Fabbrini G , et al. Smoking habits in multiple system atrophy and progressive supranuclear palsy. Neurology 2000; 54: 114–19.